ILD, hospital admissions 3, with pneumonia sepsis

ILD_HOSPITAL_PNEUMONIA_SEPSIS

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions PULM_PNEUMONIA_SEPSIS	81046
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints ILD_HOSPITAL	3137
6. Filter based on genotype QC (FinnGen only)	3137

Control definitions (FinnGen only)

Control conditions: not PULM_PNEUMONIA_SEPSIS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ILD_HOSPITAL_PNEUMONIA_SEPSIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!PULM_PNEUMONIA_SEPSIS
SEX
INCLUDE	ILD_HOSPITAL
PRE_CONDITIONS
CONDITIONS	PULM_PNEUMONIA_SEPSIS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions 3, with pneumonia sepsis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3137	1234	1903
Unadjusted period prevalence (%)	0.67	0.42	0.84
Median age at first event (years)	69.71	67.03	71.45

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2755: Matched controls
27548

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

185.2

323.0

883

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

133.6

323.0

1340

194

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.1

323.0

1920

8602

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

190.5

323.0

918

TGC00

NOMESCO Finland

Bronchial lavation

45.5

323.0

670

193

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

24.0

323.0

532

272

UGC12

NOMESCO Finland

Flexible bronchoscopy

18.3

323.0

1108

975

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

28.7

323.0

953

498

H02AB06

ATC

prednisolone; systemic

10.6

323.0

2279

8570

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

10.7

323.0

1036

1467

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

168.0

323.0

1450

181

J01MA14

ATC

moxifloxacin; systemic

12.3

323.0

687

726

J18.9

ICD-10 Finland

Pneumonia, unspecified

270.3

323.0

2414

700

R06.0

ICD-10 Finland

Dyspnoea

4.3

246.3

1221

4287

J96.1

ICD-10 Finland

Chronic respiratory failure

24.0

228.2

332

156

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

8.0

227.8

565

861

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

226.1

1422

6036

R03AC02

ATC

salbutamol; inhalant

3.5

205.8

1697

8702

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

5.7

205.3

666

1447

XG410

NOMESCO Finland

Flow-volume spirometry

10.6

199.8

411

449

GD1AD

NOMESCO Finland

Thorax CT examination

10.9

197.4

399

421

C03CA01

ATC

furosemide; systemic

3.4

196.3

1416

6465

L04AX01

ATC

azathioprine; systemic

11.8

191.7

371

358

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

8.0

188.9

464

683

R03BB04

ATC

tiotropium bromide; inhalant

5.5

188.6

627

1388

J01MA12

ATC

levofloxacin; systemic

4.1

186.8

889

2849

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

8.0

186.1

456

668

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.4

185.1

793

2298

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

14.1

177.6

315

250

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.2

173.8

781

2349

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

7.5

165.9

423

652

284

Kela drug reimbursment

Nintedanib and pirfenidone

62.7

165.3

193

A02BC02

ATC

pantoprazole; systemic

3.0

145.6

2033

13367

R50.9

ICD-10 Finland

Fever, unspecified

4.3

143.0

602

1664

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

10.5

142.8

291

305

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.9

137.2

496

1170

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.4

137.2

565

1523

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

43.1

136.1

170

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

133.7

1441

7886

356

Kela drug reimbursment

Nintedanib and pirfenidone

65.1

132.7

154

L04AA06

ATC

mycophenolic acid; systemic

21.3

129.8

195

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

9.2

129.1

283

337

L04AX05

ATC

pirfenidone; oral

82.0

124.6

140

I50.9

ICD-10 Finland

Heart failure, unspecified

3.4

124.5

729

2634

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.2

121.6

521

1443

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.8

118.7

590

1862

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

82.2

118.4

133

J01FA06

ATC

roxithromycin; oral

2.6

114.0

1261

6786

M05BA04

ATC

alendronic acid; oral

4.3

113.7

477

1289

R81

ICPC

Pneumonia

11.8

110.1

210

191

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.7

105.5

325

628

J45.9

ICD-10 Finland

Asthma, unspecified

3.2

105.1

644

2367

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

102.9

786

3349

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

97.2

101.8

112

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.0

99.0

219

262

J47

ICD-10 Finland

Bronchiectasis

13.6

98.2

175

137

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

+∞

97.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.2

96.6

326

698

P01BA02

ATC

hydroxychloroquine; oral

4.4

95.3

384

988

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

+∞

94.3

R02

ICPC

Shortness of breath/dyspnoea

3.5

94.0

509

1688

J01AA02

ATC

doxycycline; systemic

2.5

92.1

2187

16615

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

90.7

666

2735

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.9

90.6

680

2830

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

24.5

90.1

129

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

6.3

87.2

247

426

J01CA04

ATC

amoxicillin; systemic

2.4

86.8

2109

15885

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

108.1

86.5

H02AB07

ATC

prednisone; oral

3.1

85.9

553

2071

Z94.2

ICD-10 Finland

Lung transplant status

430.3

84.5

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.9

80.9

287

644

GDG10

NOMESCO Finland

Bilateral transplantation of lung

398.3

78.2

I50.0

ICD-10 Finland

Congestive heart failure

3.6

78.1

400

1257

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.6

76.6

706

3272

XG466

NOMESCO Finland

Sleep oxymetry

6.7

75.0

201

321

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.5

74.6

287

698

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

73.6

589

2507

J45.1

ICD-10 Finland

Nonallergic asthma

4.4

73.6

289

717

R4110

NOMESCO Finland

Physiotherapy

2.3

73.5

853

4440

WX892

NOMESCO Finland

Monitored bed care

3.8

73.4

339

975

R05

ICD-10 Finland

Cough

2.6

73.0

652

2956

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

72.8

481

1814

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.7

72.6

353

1060

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.2

70.1

923

5080

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

350.6

68.9

L01XE31

ATC

[U] nintedanib; oral

49.6

67.8

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

76.1

65.4

L04AD01

ATC

ciclosporin; systemic

12.0

65.2

122

106

A07EC01

ATC

sulfasalazine; oral, rectal

3.6

64.5

319

967

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

63.7

940

5388

N02AX02

ATC

tramadol; systemic, rectal

2.0

63.0

1266

8226

ZX120

NOMESCO Finland

Intravenous

3.2

61.8

355

1204

J12.8

ICD-10 Finland

Other viral pneumonia

+∞

61.7

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

12.7

60.9

111

127

Kela drug reimbursment

Transplant complication

13.5

60.5

107

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

110.9

60.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

59.4

766

4112

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.7

59.2

157

246

J43.9

ICD-10 Finland

Emphysema, unspecified

8.8

58.6

129

152

A02BC01

ATC

omeprazole; systemic

2.1

57.9

902

5243

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.6

57.7

214

499

A07AA02

ATC

nystatin; oral

3.7

57.4

272

793

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

56.5

599

2923

R04.2

ICD-10 Finland

Haemoptysis

5.1

56.5

189

395

C07AB07

ATC

bisoprolol; oral

1.9

56.1

1526

10912

R03AK07

ATC

formoterol and budesonide; inhalant

2.5

56.0

513

2318

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

558.8

55.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

55.6

393

1529

A03

ICPC

Fever

2.8

54.7

387

1503

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.4

54.2

281

880

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.6

53.2

263

793

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.7

53.2

252

734

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.7

52.9

159

293

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

52.5

644

3350

J15.8

ICD-10 Finland

Other bacterial pneumonia

62.3

52.5

N02AA05

ATC

oxycodone; systemic

2.4

52.3

537

2567

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

5.9

52.0

151

267

R28

ICPC

Limited function/disability (R)

10.7

51.6

102

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

4.8

51.6

180

393

L04AA13

ATC

leflunomide; oral

6.6

50.8

136

216

J01FF01

ATC

clindamycin; systemic

2.1

50.7

762

4317

J96.0

ICD-10 Finland

Acute respiratory failure

12.1

50.3

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

17.1

50.0

JN4BD

NOMESCO Finland

Extensive body CT

2.6

49.9

410

1737

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

49.3

789

4575

WW200

NOMESCO Finland

Immunization

6.0

48.1

138

240

J01DB01

ATC

cefalexin; oral

1.9

48.0

2074

16926

B01AA03

ATC

warfarin; systemic

2.0

47.3

801

4732

ZX108

NOMESCO Finland

Inhalation

24.5

47.2

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.3

46.5

149

296

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

32.8

46.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

45.8

233

717

R03BA08

ATC

ciclesonide; inhalant

3.2

44.7

253

842

R03BA05

ATC

fluticasone; inhalant

2.3

44.4

493

2427

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

444.5

44.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

43.7

1177

8119

48609

ICD-8 Finland

Pneumonia, unspecified

+∞

42.8

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

5.8

42.7

125

223

R03BA02

ATC

budesonide; inhalant

2.2

42.2

478

2368

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

42.2

441

2105

WX725

NOMESCO Finland

Noninvasive ventilation

4.0

41.9

174

451

R03BA01

ATC

beclometasone; inhalant

2.4

41.8

406

1870

R05

ICPC

Cough

2.1

41.7

590

3221

R03AK08

ATC

formoterol and beclometasone; inhalant

4.7

41.5

147

326

A28

ICPC

Limited function/disability NOS

2.1

41.2

548

2914

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

10.5

41.0

R03DA04

ATC

theophylline; systemic, rectal

3.3

40.7

221

713

N02BE01

ATC

paracetamol; systemic, rectal

1.9

39.9

2254

19334

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

33.1

39.8

R03DC03

ATC

montelukast; oral

2.4

39.7

390

1802

A41.9

ICD-10 Finland

Sepsis, unspecified

4.2

39.6

156

385

A02BC05

ATC

esomeprazole; systemic

1.7

39.2

1073

7362

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.1

38.4

157

401

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

6.2

37.9

105

175

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.9

37.7

242

876

J01FA10

ATC

azithromycin; systemic

1.7

37.6

1258

9129

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

37.2

844

5437

WX872

NOMESCO Finland

Intensive care

3.3

37.1

195

613

M04AA01

ATC

allopurinol; systemic

2.1

37.1

490

2588

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

36.6

408

1997

XW000

NOMESCO Finland

Bone marrow biopsy

3.7

36.0

167

476

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

35.9

836

5417

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.3

35.2

110

213

R99

ICPC

Respiratory disease other

6.2

35.2

161

WX722

NOMESCO Finland

PEEP

3.4

35.1

180

556

48499

ICD-8 Finland

Acute interstitial pneumonia

67.5

35.0

Z51.5

ICD-10 Finland

Palliative care

2.8

34.7

244

934

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

10.5

34.6

H02AB04

ATC

methylprednisolone; systemic

2.2

34.1

407

2050

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

17.2

34.1

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

6.2

34.1

156

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.5

33.7

124

286

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

33.6

268

1103

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

33.6

424

2186

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

33.5

158

457

XX4BW

NOMESCO Finland

41.5

33.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

33.0

713

4483

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

12.8

33.0

R03AC12

ATC

salmeterol; inhalant

3.4

32.8

165

502

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.1

32.6

106

215

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

15.9

32.5

A01AB09

ATC

miconazole; local oral

2.4

32.2

285

1239

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

32.2

297

1323

J01FA15

ATC

telithromycin; oral

2.6

31.9

258

1072

N05CF01

ATC

zopiclone; oral

1.7

31.8

915

6266

JN4AD

NOMESCO Finland

Body CT examination

2.5

31.6

264

1113

A02BC03

ATC

lansoprazole; oral

1.7

31.6

823

5474

J45.8

ICD-10 Finland

Mixed asthma

4.5

31.6

115

263

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

31.3

GDA10

NOMESCO Finland

Biopsy of lung

28.4

31.1

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

12.4

31.0

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

12.4

31.0

J46

ICD-10 Finland

Status asthmaticus

5.3

30.9

185

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.5

30.9

177

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

30.8

221

855

A46

ICD-10 Finland

Erysipelas

2.0

30.8

423

2255

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

30.7

250

1039

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.6

30.2

165

N03AX16

ATC

pregabalin; oral

1.8

30.2

608

3722

WX726

NOMESCO Finland

High-flow oxygen therapy

59.0

30.1

WX882

NOMESCO Finland

High dependency care

4.4

30.0

111

258

R03BB01

ATC

ipratropium bromide; inhalant

3.1

29.9

170

565

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.7

29.9

223

884

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

29.5

314

1496

SPAT1255

SPAT

Intravenous administration of medicine

2.7

29.4

212

822

L04AA01

ATC

[U] ciclosporin; systemic

7.0

29.3

106

J80

ICD-10 Finland

Adult respiratory distress syndrome

24.4

29.2

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

57.3

29.1

R06AE07

ATC

cetirizine; oral

1.6

29.1

959

6776

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

29.1

247

1052

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.8

28.7

147

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

28.6

349

1768

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

28.5

234

978

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

28.5

502

2930

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

28.4

795

5364

J01FA09

ATC

clarithromycin; systemic

1.7

28.3

709

4635

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

64.7

27.9

M05BA07

ATC

risedronic acid; oral

3.5

27.9

137

409

L88

ICPC

Rheumatoid/seropositive arthritis

3.7

27.9

127

357

J20

ICD-10 Finland

Acute bronchitis

2.4

27.9

255

1126

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

27.8

320

1577

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

78.4

27.8

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.8

27.5

119

320

J01MA02

ATC

ciprofloxacin; systemic

1.6

27.4

1079

7951

J01DA01

ATC

[U] cefalexin; systemic

1.6

27.3

1554

12515

WX721

NOMESCO Finland

Oxygen concentrator therapy

30.4

27.2

J18

ICD-10 Finland

Pneumonia, organism unspecified

12.5

26.8

AA1AD

NOMESCO Finland

CT of head and brain

1.7

26.7

690

4537

L01EX09

ATC

nintedanib; oral

28.0

26.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

26.5

324

1639

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

26.4

235

1025

F1246

NOMESCO Finland

26.0

26.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

26.2

926

6624

WZC30

NOMESCO Finland

Teaching

2.0

26.1

369

1980

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

26.1

297

1456

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.5

26.0

145

R06.2

ICD-10 Finland

Wheezing

3.4

25.9

132

406

J84

ICD-10 Finland

Other interstitial pulmonary diseases

136.2

25.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

25.5

385

2114

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

25.5

343

1806

SPAT1263

SPAT

Sampling

1.6

25.4

1072

7989

C01DA14

ATC

isosorbide mononitrate; oral

1.7

25.4

606

3884

AN1

Coronary angiography

1.9

25.2

431

2476

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

4.5

25.2

207

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.6

25.2

119

345

D07AC01

ATC

betamethasone; topical

1.6

25.1

864

6120

48509

ICD-8 Finland

Bronchopneumonia, unspecified

+∞

25.0

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.0

25.0

154

541

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

6.8

24.9

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.1

24.9

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

131.1

24.6

E0000UV

ATC

1.6

24.6

922

6662

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.9

24.5

119

TK800

NOMESCO Finland

Hemodialysis

5.0

24.4

165

J86.9

ICD-10 Finland

Pyothorax without fistula

14.3

24.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.3

24.2

221

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

56.5

24.0

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.9

24.0

153

550

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.2

23.9

147

J43.8

ICD-10 Finland

Other emphysema

22.9

23.9

C03DA01

ATC

spironolactone; oral

2.0

23.8

344

1858

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.7

23.7

179

120

Kela drug reimbursment

Hypogammaglobulinaemia

241.9

23.7

J96.9

ICD-10 Finland

Respiratory failure, unspecified

12.2

23.2

B01AB05

ATC

enoxaparin; parenteral

1.6

23.2

811

5743

M10.9

ICD-10 Finland

Gout, unspecified

2.3

23.2

230

1057

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.2

23.0

217

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

22.9

417

2446

XG460

NOMESCO Finland

Short time oxymetry

4.5

22.9

186

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.4

22.7

192

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

231.7

22.6

2AX04

NOMESCO Finland

121.0

22.6

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

13.2

22.4

R03AC03

ATC

terbutaline; inhalant

1.9

22.4

333

1818

I50.1

ICD-10 Finland

Left ventricular failure

2.6

22.3

173

698

R03AC13

ATC

formoterol; inhalant

2.8

22.2

145

530

M81.4

ICD-10 Finland

Drug-induced osteoporosis

16.9

22.2

M05BX04

ATC

denosumab; parenteral

2.6

22.2

166

658

SPAT1262

SPAT

Handing over of treatment supplies

1.7

22.1

531

3390

RS123

NOMESCO Finland

63.0

21.9

J05AB11

ATC

valaciclovir; oral

1.9

21.8

325

1774

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.9

21.8

133

466

R95

ICPC

Chron obstructive pulmonary disease

3.7

21.6

261

S97

ICPC

Chronic ulcer skin

2.5

21.6

175

725

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.9

21.5

148

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

21.5

425

2557

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.4

21.4

183

779

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

21.3

208

948

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.1

21.3

G47.3

ICD-10 Finland

Sleep apnoea

1.7

21.3

493

3110

E000001

ATC

1.7

21.3

480

3007

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.4

21.2

177

F2680

NOMESCO Finland

20.9

21.2

J43.2

ICD-10 Finland

Centrilobular emphysema

15.6

21.0

R53

ICD-10 Finland

Malaise and fatigue

1.7

21.0

502

3196

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.7

20.9

157

SPAT1325

SPAT

Vaccination

1.5

20.9

991

7493

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

20.9

590

3936

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

+∞

20.9

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

10.7

20.8

L01AA01

ATC

cyclophosphamide; systemic

11.7

20.7

M01CB01

ATC

sodium aurothiomalate; parenteral

4.9

20.5

138

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

42.0

20.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

20.3

762

5453

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

20.2

115

384

C09AA05

ATC

ramipril; oral

1.5

20.2

762

5462

5AB14

NOMESCO Finland

48.4

20.1

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

20.1

189

844

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

20.1

1041

7998

A06AD11

ATC

lactulose; oral

1.7

19.9

446

2784

J02AC01

ATC

fluconazole; systemic

1.5

19.9

752

5388

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.6

19.8

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

19.6

334

1909

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

19.5

743

5326

J02AC03

ATC

voriconazole; systemic

40.4

19.5

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

21.7

19.5

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

21.7

19.5

WW500

NOMESCO Finland

Blood transfusion

2.8

19.4

126

457

B02.9

ICD-10 Finland

Zoster without complication

2.3

19.3

181

808

I50

ICD-10 Finland

Heart failure

2.8

19.0

122

443

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

18.9

826

6097

SPAT1254

SPAT

Administration of medicine

1.8

18.9

389

2361

J94.1

ICD-10 Finland

Fibrothorax

34.5

18.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

18.8

116

410

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.2

18.7

200

953

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

7.4

18.7

R03AK11

ATC

formoterol and fluticasone; inhalant

4.0

18.5

192

R05FB02

ATC

cough suppressants and expectorants

1.5

18.3

956

7319

N06AX11

ATC

mirtazapine; oral

1.5

18.3

706

5062

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

18.3

418

2618

WX002

NOMESCO Finland

Sedation and analgesia

1.6

18.3

518

3443

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.6

18.1

L04AB04

ATC

adalimumab; parenteral

5.3

18.1

105

XX9XE

NOMESCO Finland

Other ultrasound examination

9.4

18.1

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

18.1

173

782

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

18.0

767

5620

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

17.9

668

4750

L28

ICPC

Limited function/disability (L)

1.7

17.9

447

2871

H02AB09

ATC

hydrocortisone; systemic

4.2

17.8

165

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

26.9

17.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

17.8

207

1022

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

20.2

17.7

3A006

NOMESCO Finland

+∞

17.7

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.4

17.7

100

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

36.9

17.6

XG405

NOMESCO Finland

Education on PEF monitoring

5.1

17.6

109

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

17.5

214

1078

A04

ICPC

Weakness/tiredness general

1.8

17.5

334

1980

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.8

17.5

115

422

RK320

NOMESCO Finland

5.9

17.4

ZXA10

NOMESCO Finland

Bilateral

1.6

17.2

513

3452

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

17.2

362

2209

N02AA01

ATC

morphine; systemic, rectal

4.1

17.1

162

UJF32

NOMESCO Finland

Coloscopy

1.5

17.1

681

4906

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

17.1

110

400

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

17.1

191

928

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

17.1

843

6359

M31.3

ICD-10 Finland

Wegener granulomatosis

16.0

17.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

16.9

496

3320

RK110

NOMESCO Finland

6.6

16.9

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

10.1

16.9

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.9

16.8

180

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.9

16.8

185

J05AB01

ATC

aciclovir; systemic

1.6

16.7

475

3153

C01AA05

ATC

digoxin; systemic

1.8

16.7

297

1718

N18.8

ICD-10 Finland

Other chronic renal failure

2.9

16.5

101

355

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

170.9

16.5

J99.0

ICD-10 Finland

Rheumatoid lung disease

170.9

16.5

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.6

16.5

125

501

ZXA05

NOMESCO Finland

Left side

1.5

16.4

686

4989

M33.2

ICD-10 Finland

Polymyositis

20.2

16.4

XJC10

NOMESCO Finland

Oesophageal pH monitoring

9.5

16.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

16.3

146

639

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

16.3

652

4693

GX1K5

NOMESCO Finland

Diffusion capacity

14.3

16.3

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

16.3

253

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

16.3

175

833

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

16.2

171

809

GAA31

NOMESCO Finland

Thoracoscopy

8.8

16.2

5BA08

NOMESCO Finland

9.3

16.1

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

16.1

157

717

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

16.1

757

5642

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.2

16.0

272

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

47.8

16.0

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

16.0

279

1604

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

16.0

263

1483

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.3

15.8

253

A02BA02

ATC

ranitidine; systemic

1.5

15.8

549

3825

A01AB04

ATC

amphotericin B; local oral

2.4

15.7

141

616

ZXA00

NOMESCO Finland

Right side

1.5

15.7

724

5368

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

3.0

15.7

310

D07AC13

ATC

mometasone; topical

1.5

15.7

678

4956

1240

FHL

Bronchoscopy

4.5

15.7

124

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

15.6

749

5595

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

15.6

208

1085

WX110

NOMESCO Finland

Local anesthesy

1.4

15.5

1489

12637

D07AB08

ATC

desonide; topical

1.9

15.4

252

1417

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.9

15.3

160

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.1

15.1

SPAT1060

SPAT

Administration of oxygen

14.0

15.0

WZA10

NOMESCO Finland

Long statement of health and health related matters

5.3

15.0

R4190

NOMESCO Finland

Nutritional therapy

3.2

14.9

253

J94.8

ICD-10 Finland

Other specified pleural conditions

3.8

14.9

164

J45

ICD-10 Finland

Asthma

2.0

14.8

204

1076

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

14.8

260

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

14.8

262

1513

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

14.8

229

1262

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

14.7

262

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.4

14.6

119

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

4.4

14.6

119

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.2

14.6

252

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

14.6

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.0

14.6

148

N05CD07

ATC

temazepam; oral

1.7

14.5

356

2265

N03AX12

ATC

gabapentin; oral

1.7

14.5

357

2275

J01GB01

ATC

tobramycin; inhalant, parenteral

150.7

14.5

207

Kela drug reimbursment

Chronic arrhythmias

1.6

14.4

463

3161

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

12.6

14.4

L04AB01

ATC

etanercept; parenteral

5.3

14.3

R74

ICPC

Upper respiratory infection acute

1.6

14.3

434

2920

R96

ICPC

Asthma

2.0

14.2

195

1029

RS230

NOMESCO Finland

9.7

14.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

14.1

973

7754

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

14.0

136

621

J93.8

ICD-10 Finland

Other pneumothorax

8.9

13.9

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

12.7

13.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

13.9

139

642

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

13.8

248

1436

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

7.8

13.8

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

17.6

13.8

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

13.8

289

1759

M05.1

ICD-10 Finland

Rheumatoid lung disease

53.6

13.8

J67.0

ICD-10 Finland

Farmer lung

53.6

13.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

13.7

668

4982

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

13.7

146

694

RK250

NOMESCO Finland

10.5

13.7

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.7

13.7

340

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

13.6

140

654

R01AD08

ATC

fluticasone; nasal

1.5

13.6

557

4009

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

75.5

13.6

B59

ICD-10 Finland

Pneumocystosis

75.5

13.6

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

140.6

13.5

M34.1

ICD-10 Finland

CR(E)ST syndrome

10.1

13.4

B01AC04

ATC

clopidogrel; oral

1.5

13.4

483

3379

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.5

13.4

180

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

13.3

211

1174

L03AA02

ATC

filgrastim; parenteral

3.0

13.3

257

C10AA03

ATC

pravastatin; oral

1.8

13.2

229

1314

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.7

13.2

347

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

13.2

135

631

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

9.7

13.2

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

13.2

221

1254

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.3

13.1

118

517

WX730

NOMESCO Finland

Conventional respirator

3.9

13.0

139

TGD00

NOMESCO Finland

Needle biopsy of lung

8.8

13.0

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.9

736

5648

GX2C5

NOMESCO Finland

Short-lasting oximetry

19.1

12.9

GD1UN

NOMESCO Finland

Lung circulation SPECT

6.4

12.9

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.0

12.9

167

864

B01AF02

ATC

apixaban; oral

1.7

12.9

302

1896

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

12.8

164

843

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.0

12.8

245

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

6.6

12.8

RS220

NOMESCO Finland

4.7

12.7

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

12.7

191

1044

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.8

12.7

290

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.2

12.7

205

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.5

12.6

168

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.9

12.6

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.3

12.6

109

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

15.5

12.6

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

70.2

12.6

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

70.2

12.6

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

70.2

12.6

M79.6

ICD-10 Finland

Pain in limb

1.4

12.6

783

6098

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

+∞

12.5

J42

ICD-10 Finland

Unspecified chronic bronchitis

4.6

12.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

12.4

645

4858

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

130.5

12.4

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

130.5

12.4

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

12.4

117

528

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

12.4

117

528

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.1

12.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

12.4

220

Angiography of the heart and coronary arteries

1.8

12.3

231

1357

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

12.3

312

2005

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.5

12.2

M54.5

ICD-10 Finland

Low back pain

1.4

12.2

661

5018

R60.0

ICD-10 Finland

Localized oedema

1.7

12.1

286

1800

R11

ICD-10 Finland

Nausea and vomiting

1.9

12.1

173

929

L04AA24

ATC

abatacept; parenteral

12.4

12.1

3AC01

NOMESCO Finland

5.4

12.1

E000003

ATC

2.3

12.0

109

482

SPAT1260

SPAT

Consultation of another employee

1.5

12.0

424

2945

XX4AW

NOMESCO Finland

26.8

12.0

1CX01

NOMESCO Finland

26.8

12.0

GX1D5

NOMESCO Finland

Flow volume spirometry

21.4

12.0

Z57.2

ICD-10 Finland

Occupational exposure to dust

8.7

12.0

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

12.0

203

A02BA03

ATC

famotidine; systemic

2.2

11.9

128

610

J98.4

ICD-10 Finland

Other disorders of lung

13.4

11.9

1XC02

NOMESCO Finland

5.7

11.9

B34.9

ICD-10 Finland

Viral infection, unspecified

3.4

11.9

166

N19

ICD-10 Finland

Unspecified kidney failure

2.3

11.9

113

511

R29

ICPC

Respiratory symptom/complaint other

2.0

11.8

142

713

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

11.8

218

1273

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

11.8

214

1245

UJD02

NOMESCO Finland

Gastroscopy

2.1

11.8

130

631

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

11.7

221

1300

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.4

11.7

405

RS221

NOMESCO Finland

4.1

11.7

108

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

5.0

11.7

R04.0

ICD-10 Finland

Epistaxis

1.8

11.7

208

1203

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.6

11.6

143

J01FA01

ATC

erythromycin; systemic

1.7

11.6

247

1508

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

65.2

11.6

ED1AA

NOMESCO Finland

Mandipular X-ray examination

8.1

11.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

11.5

219

1291

304

Kela drug reimbursment

Dornase alfa

+∞

11.5

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

11.5

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

11.5

AK3

BLTX (both lung transplants)

+∞

11.5

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

120.4

11.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

11.4

125

606

XQ800

NOMESCO Finland

Prick test

2.1

11.4

122

584

A01

ICPC

Pain general/multiple sites

1.9

11.3

174

960

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

11.3

252

1563

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

11.3

208

1217

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

6.6

11.2

R01AD09

ATC

mometasone; nasal

1.4

11.2

864

6949

M34.0

ICD-10 Finland

Progressive systemic sclerosis

25.1

11.1

R2110

NOMESCO Finland

Giving the first information

2.0

11.1

142

731

R4120

NOMESCO Finland

Occupational therapy

2.0

11.1

142

731

R24

ICPC

Haemoptysis

7.1

11.0

WX720

NOMESCO Finland

Own respiration

2.4

11.0

405

TGA30

NOMESCO Finland

Thoracocentesis

5.6

11.0

A10AE04

ATC

insulin glargine; parenteral

1.7

11.0

214

1271

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

11.0

197

1143

N05BA04

ATC

oxazepam; oral

1.4

11.0

533

3953

B01AB10

ATC

tinzaparin; parenteral

1.9

10.9

167

917

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

43.5

10.9

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

15.5

10.8

R13

ICD-10 Finland

Dysphagia

1.9

10.8

160

869

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

10.8

109

510

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.3

10.8

158

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

10.8

164

901

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.0

10.8

136

698

N06AA09

ATC

amitriptyline; systemic

1.7

10.8

234

1440

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.6

10.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

10.7

427

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

6.1

10.7

D07AA02

ATC

hydrocortisone; topical

1.6

10.7

271

1738

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

6.7

10.7

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

10.7

112

531

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.1

10.6

187

P01AB01

ATC

metronidazole; oral, rectal

1.3

10.6

819

6573

I26

ICD-10 Finland

Pulmonary embolism

5.0

10.6

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

8.0

10.6

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.9

10.6

109

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.9

10.6

216

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

11.2

10.5

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

6.5

10.5

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

14.2

10.5

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.8

10.5

247

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.0

10.4

205

J17.3

ICD-10 Finland

Pneumonia in parasitic diseases

+∞

10.4

J01XB01

ATC

colistin; inhalant, parenteral

+∞

10.4

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.9

10.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

10.4

578

4394

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

16.1

10.3

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.2

10.3

169

XF404

NOMESCO Finland

Ambulatory ECG

1.6

10.3

244

1535

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.3

394

2779

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

8.2

10.3

N17.8

ICD-10 Finland

Other acute renal failure

4.1

10.3

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

10.3

261

1674

S22.3

ICD-10 Finland

Fracture of rib

1.9

10.3

156

856

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.0

10.3

WNF00

NOMESCO Finland

Infection source and contact determination

8.8

10.3

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

10.3

159

M33.1

ICD-10 Finland

Other dermatomyositis

18.8

10.2

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

23.4

10.2

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.7

10.2

245

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

10.2

232

GDC00

NOMESCO Finland

Lobectomy of lung

5.9

10.1

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.4

10.1

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.9

10.0

206

NHQ40

NOMESCO Finland

Amputation of toe

3.0

10.0

184

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

10.0

427

3083

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

8.5

10.0

N06AB04

ATC

citalopram; systemic

1.5

10.0

428

3091

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

10.0

548

4149

ZX121

NOMESCO Finland

Central venous catheter

10.1

10.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

10.0

285

R03AC18

ATC

indacaterol; inhalant

5.3

10.0

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

5.5

9.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

9.9

446

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

3.5

9.9

126

E000002

ATC

1.7

9.9

224

1394

318

Kela drug reimbursment

Teriparatide

6.7

9.9

I27.0

ICD-10 Finland

Primary pulmonary hypertension

16.7

9.9

C08CA01

ATC

amlodipine; oral

1.3

9.8

958

7951

UGC02

NOMESCO Finland

Rigid bronchoscopy

10.6

9.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

9.7

445

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

55.2

9.6

J98.2

ICD-10 Finland

Interstitial emphysema

55.2

9.6

M01AH02

ATC

rofecoxib; oral

1.5

9.6

323

2215

XX7LW

NOMESCO Finland

11.4

9.5

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

10.1

9.5

A11CC03

ATC

alfacalcidol; systemic

2.8

9.5

209

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.8

9.5

100

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.5

447

3288

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

9.4

175

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

9.4

176

1035

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

4.1

9.4

M05BA06

ATC

ibandronic acid; systemic

2.8

9.4

213

ZX100

NOMESCO Finland

Oral

3.0

9.4

170

291

Kela drug reimbursment

Tofacitinib

17.6

9.4

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

4.3

9.4

R01AD12

ATC

fluticasone furoate; nasal

1.4

9.4

486

3638

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.4

9.4

132

K77

ICPC

Heart failure

2.6

9.4

263

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.2

9.4

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.4

9.3

127

6BA02

NOMESCO Finland

12.4

9.3

A02BA04

ATC

nizatidine; systemic

1.7

9.3

210

1304

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

9.3

178

1054

UDC00

NOMESCO Finland

Ear microscopy

1.7

9.3

178

1054

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.8

9.3

102

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

9.2

153

867

R03BB06

ATC

glycopyrronium bromide; inhalant

6.4

9.2

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

9.2

179

1066

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.5

9.2

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

13.7

9.2

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

9.2

451

J01DA06

ATC

[U] cefuroxime; systemic

1.5

9.1

297

2022

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.3

9.1

EB1WA

NOMESCO Finland

6.3

9.1

GX2D5

NOMESCO Finland

Sleep oximetry

8.3

9.1

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

9.0

201

1245

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

9.0

L01BB05

ATC

fludarabine; systemic

36.8

9.0

ZX197

NOMESCO Finland

36.8

9.0

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

36.8

9.0

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

36.8

9.0

D07XC01

ATC

betamethasone, combinations; topical

1.5

9.0

280

1885

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

8.9

143

801

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

8.9

429

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

8.9

370

2651

RD210

NOMESCO Finland

3.5

8.9

116

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.6

8.9

251

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

24.1

8.9

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.7

8.9

101

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

8.9

193

1188

N05BA01

ATC

diazepam; systemic, rectal

1.5

8.9

289

1970

NDG30

NOMESCO Finland

Fusion of wrist, total

5.5

8.9

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

5.5

8.9

JN4CD

NOMESCO Finland

Very extensive body CT

2.0

8.9

106

533

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.7

8.9

212

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.0

8.8

113

585

A07AA09

ATC

vancomycin; oral

3.8

8.8

M25.5

ICD-10 Finland

Pain in joint

1.4

8.8

534

4106

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.4

8.8

118

R4130

NOMESCO Finland

Speech therapy

2.7

8.8

214

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

5.6

8.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

8.7

183

1118

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

8.7

115

601

B01AB04

ATC

dalteparin; parenteral

1.9

8.7

127

688

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

8.7

552

4278

N07BA03

ATC

varenicline; oral

2.3

8.7

355

H26.3

ICD-10 Finland

Drug-induced cataract

6.6

8.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

8.6

153

887

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

8.6

140

788

ZX114

NOMESCO Finland

Intramuscular

3.4

8.6

120

N06AX16

ATC

venlafaxine; oral

1.6

8.6

206

1303

RK120

NOMESCO Finland

8.2

8.6

S18

ICPC

Laceration/cut

1.3

8.6

1007

8527

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

8.5

236

1547

R04

ICPC

Breathing problem other

2.4

8.5

303

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.5

570

4451

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

8.5

325

2294

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.3

8.5

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

27.6

8.5

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.7

8.4

160

947

Z94.3

ICD-10 Finland

Heart and lungs transplant status

90.3

8.4

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

90.3

8.4

L95

ICPC

Osteoporosis

2.3

8.4

337

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.3

8.4

338

D72.1

ICD-10 Finland

Eosinophilia

7.9

8.3

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

+∞

8.3

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

+∞

8.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.9

8.3

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

5.0

8.3

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

8.3

430

H05AA02

ATC

teriparatide; parenteral

6.2

8.3

M70.2

ICD-10 Finland

Olecranon bursitis

2.2

8.3

396

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.4

8.2

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

8.2

449

3388

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.2

350

2526

WX740

NOMESCO Finland

Nitrogen oxide therapy

14.5

8.2

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

8.2

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

8.1

189

1186

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

8.1

115

618

V03AE01

ATC

polystyrene sulfonate; oral

3.3

8.1

115

FXE00

NOMESCO Finland

Use of ECLA

33.4

8.1

WW409

NOMESCO Finland

Other aferesis

17.2

8.1

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

17.2

8.1

R01

ICPC

Pain respiratory system

3.5

8.1

105

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

8.1

121

B37.0

ICD-10 Finland

Candidal stomatitis

3.9

8.0

A01AB10

ATC

natamycin; local oral

2.3

8.0

322

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

6.3

8.0

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

4.3

8.0

XF402

NOMESCO Finland

ECG with work load test

1.5

8.0

285

1980

J01DC02

ATC

cefuroxime; systemic

2.0

8.0

506

M35.1

ICD-10 Finland

Other overlap syndromes

7.2

7.9

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

7.9

327

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

7.9

899

7553

A12BA01

ATC

potassium chloride; oral

1.8

7.9

136

780

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

7.9

157

942

M02AA07

ATC

piroxicam; topical

1.3

7.9

870

7288

K78

ICPC

Atrial fibrillation/flutter

1.6

7.9

220

1448

-1

NOMESCO Finland

1.3

7.8

587

4659

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

7.8

901

7589

SPAT1059

SPAT

Spirometry at the office

1.9

7.8

118

648

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

4.7

7.8

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.7

7.8

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

10.8

7.8

N05AA02

ATC

levomepromazine; systemic

2.2

7.8

367

C10AA01

ATC

simvastatin; oral

1.3

7.8

1232

10786

WX213

NOMESCO Finland

Lower leg blockade

4.8

7.7

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

7.7

100

521

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

45.1

7.7

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

45.1

7.7

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

15.0

7.7

RK310

NOMESCO Finland

15.0

7.7

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

5.0

7.7

A04AA01

ATC

ondansetron; systemic, rectal

1.8

7.7

132

758

A91

ICPC

Abnormal result investigation NOS

2.0

7.7

514

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

7.7

436

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.9

7.6

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.6

7.6

196

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.4

7.6

E86

ICD-10 Finland

Volume depletion

2.5

7.6

233

293

Kela drug reimbursment

Baricitinib

18.4

7.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

7.6

1005

8600

B07.9

ICD-10 Finland

Verruca simplex

2.4

7.6

263

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

8.9

7.5

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.6

7.5

192

R05CB01

ATC

acetylcysteine; inhalant, oral

2.6

7.4

204

A12AA04

ATC

calcium carbonate; oral

3.1

7.4

129

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.1

7.4

388

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

80.3

7.4

5CM18

NOMESCO Finland

7.7

7.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.8

7.4

158

132

Kela drug reimbursment

Sarcoidosis

4.6

7.4

K07

ICPC

Swollen ankles/oedema

1.8

7.4

115

643

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

5.6

7.4

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.3

1455

13036

212

Kela drug reimbursment

Gout

2.2

7.3

303

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

7.3

118

665

R03DC01

ATC

zafirlukast; oral

2.8

7.3

153

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

+∞

7.3

B05XA03

ATC

sodium chloride; parenteral

+∞

7.3

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

+∞

7.3

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

+∞

7.3

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

10.9

7.3

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

4.2

7.3

L04AB05

ATC

certolizumab pegol; parenteral

9.4

7.3

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

7.3

166

WYA20

NOMESCO Finland

Home visit

2.8

7.3

160

Z94.0

ICD-10 Finland

Kidney transplant status

4.5

7.2

TNG10

NOMESCO Finland

Puncture of knee

3.7

7.2

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

7.2

126

3006

Kela drug reimbursment

Baricitinib

15.8

7.2

E000006

ATC

1.7

7.2

147

891

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

7.2

258

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

7.2

395

2980

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

7.2

171

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.4

7.2

248

J43.1

ICD-10 Finland

Panlobular emphysema

30.1

7.1

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

30.1

7.1

4911A

ICD-9 Finland

Chronic bronchitis, Mucopurulent chronic bronchitis

30.1

7.1

M06

ICD-10 Finland

Other rheumatoid arthritis

4.4

7.1

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

20.1

7.1

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.5

7.1

214

XJC00

NOMESCO Finland

Oesophageal manometry

6.6

7.1

ZX140

NOMESCO Finland

Intra articular

5.0

7.1

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.2

7.1

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.1

471

3667

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

12.0

7.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

7.1

114

643

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

7.1

253

1760

NG1DA

NOMESCO Finland

X-ray of knees

2.7

7.1

174

I95.9

ICD-10 Finland

Hypotension, unspecified

2.9

7.1

144

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

7.1

114

644

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.9

7.0

WW300

NOMESCO Finland

Transfer of autologic stem cells

8.8

7.0

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

7.0

251

1744

SPAT1211

SPAT

Application of soft bandage

1.6

7.0

196

1292

R03BB07

ATC

umeclidinium bromide; inhalant

4.7

7.0

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.2

7.0

107

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

7.0

245

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

7.0

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

7.0

138

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

4.1

7.0

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

7.0

172

1096

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.0

7.0

457

M48.0

ICD-10 Finland

Spinal stenosis

1.4

7.0

320

2340

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.4

6.9

239

L03AA13

ATC

pegfilgrastim; parenteral

2.2

6.9

324

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

6.9

247

1716

WX402

NOMESCO Finland

General anaesthesia

1.4

6.9

306

2220

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.5

6.9

214

E66.8

ICD-10 Finland

Other obesity

2.1

6.9

339

D01AC02

ATC

miconazole; topical

1.6

6.8

185

1210

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

6.8

387

2935

M01AB55

ATC

diclofenac, combinations; oral

1.6

6.8

172

1102

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.4

6.8

XPX04

NOMESCO Finland

Angioscopy

6.7

6.8

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

6.7

6.8

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

6.8

216

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.0

6.8

R07.3

ICD-10 Finland

Other chest pain

1.5

6.8

205

1373

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

6.8

488

Z50.1

ICD-10 Finland

Other physical therapy

1.7

6.8

126

746

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.3

6.8

RS224

NOMESCO Finland

6.1

6.8

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

5.3

6.8

WX704

NOMESCO Finland

Intubation

1.7

6.7

139

844

L04AA37

ATC

baricitinib; oral

16.7

6.7

R49.01

ICD-10 Finland

Functional dysphonia

2.3

6.7

269

J01DA08

ATC

[U] cefaclor; oral

1.6

6.7

163

1036

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

6.7

324

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.9

6.7

138

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

6.7

107

603

C02KX04

ATC

macitentan; oral

22.6

6.7

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

22.6

6.7

4040

NOMESCO Finland

22.6

6.7

J01XX08

ATC

linezolid; systemic

4.9

6.7

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

6.6

130

781

I20.09

ICD-10 Finland

Unstable angina

1.6

6.6

161

1026

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

6.6

256

1810

S29

ICPC

Skin symptom/complaint other

1.4

6.6

366

2762

K76.9

ICD-10 Finland

Liver disease, unspecified

3.1

6.6

112

R03BB05

ATC

aclidinium bromide; inhalant

7.8

6.6

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

5.9

6.6

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.6

6.6

165

1060

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.1

6.6

107

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

6.6

373

2831

L17

ICPC

Foot/toe symptom/complaint

1.3

6.6

529

4235

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.5

266

1902

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.0

6.5

113

S22.2

ICD-10 Finland

Fracture of sternum

4.3

6.5

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

6.5

441

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.7

6.5

C08CA02

ATC

felodipine; oral

1.4

6.4

262

1871

R03AC19

ATC

olodaterol; inhalant

5.7

6.4

-44

ICPC

Preventive immunization/medic

1.5

6.4

214

1465

XX1VW

NOMESCO Finland

Written report from radiologist

4.3

6.4

J98.1

ICD-10 Finland

Pulmonary collapse

4.3

6.4

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

7.4

6.4

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.6

6.4

144

900

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

6.4

394

SPAT1251

SPAT

Organisation of medication

1.9

6.4

436

C07AB02

ATC

metoprolol; systemic

1.3

6.4

588

4791

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.4

901

7737

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

8.2

6.3

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

6.3

545

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.6

6.3

169

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.0

6.3

116

RK520

NOMESCO Finland

5.2

6.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

6.3

361

348

Kela drug reimbursment

Roflumilast

11.0

6.3

R03DX07

ATC

roflumilast; oral

11.0

6.3

L04AC07

ATC

tocilizumab; parenteral

9.3

6.3

S20

ICPC

Corn/callosity

2.4

6.3

218

J93.9

ICD-10 Finland

Pneumothorax, unspecified

4.6

6.3

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.3

1035

9032

ECB20

NOMESCO Finland

Oral alveoplasty

3.7

6.3

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

6.3

103

585

J15.6

ICD-10 Finland

Pneumonia due to other Gram-negative bacteria

+∞

6.2

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

6.2

J14

ICD-10 Finland

Pneumonia due to Haemophilus influenzae

+∞

6.2

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

3.1

6.2

100

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

6.2

119

708

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

26.7

6.2

GDB01

NOMESCO Finland

Thoracoscopic resection of bullae of lung

26.7

6.2

R51.80

ICD-10 Finland

Headache

1.5

6.2

233

1639

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

6.2

112

657

RK290

NOMESCO Finland

7.0

6.2

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

7.0

6.2

W19

ICD-10 Finland

Unspecified fall

1.5

6.2

188

1263

GD1LA

NOMESCO Finland

2.6

6.2

165

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

6.2

285

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.5

6.2

HA1AA

NOMESCO Finland

X-ray mammography

1.7

6.2

132

813

GBB00

NOMESCO Finland

Tracheostomy

3.1

6.2

101

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.8

6.2

128

G53.0

ICD-10 Finland

Postzoster neuralgia

3.6

6.2

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

6.2

454

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

6.2

108

629

WVA20

NOMESCO Finland

Medicine administration

2.3

6.1

222

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.2

6.1

275

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.1

205

1409

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

6.1

414

SXC03

NOMESCO Finland

Other oral or dental procedure

3.4

6.1

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

3.5

6.1

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

6.1

252

3374

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

6.1

351

B37.08

ICD-10 Finland

Other candidal stomatitis

4.0

6.1

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

12.5

6.1

N18.0

ICD-10 Finland

End-stage renal disease

3.0

6.1

108

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

6.1

695

5815

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

8.6

6.0

S20.2

ICD-10 Finland

Contusion of thorax

1.8

6.0

557

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

6.0

526

M31.7

ICD-10 Finland

Microscopic polyangiitis

10.0

6.0

L04AA29

ATC

tofacitinib; oral

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

246

125

21.27

322.70

2.3

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

2194

11001

4.31

320.21

15.0

5.3

22.8

27.0

53.83

2143

10064

(3018010) Neutrophils/100 leukocytes in Blood

2168

10843

4.24

316.00

14.2

5.1

62.5

57.6

58.37

2114

9984

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

622

227

33.93

307.65

2.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

523

183

34.10

307.65

2.2

1.2

—

(3013115) Eosinophils [#/volume] in Blood

2309

11891

4.57

307.65

14.8

5.1

0.2

e9/l

0.14

2150

10173

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1059

2861

5.08

307.65

10.0

6.3

5.1

5.0

kpa

0.23

1015

2734

(3019198) Lymphocytes [#/volume] in Blood

2289

11747

4.51

307.65

13.9

5.0

1.8

1.9

e9/l

0.35

2124

10091

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1203

2575

6.96

307.65

2.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

447

166

31.24

307.65

1.9

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

545

897

7.14

307.65

2.6

1.7

2.3

2.6

ug/l

0.11

496

753

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

523

262

23.76

307.65

2.5

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

30.99

307.65

2.2

1.2

—

(3023368) Bacteria identified in Blood by Culture

1948

6633

6.11

307.65

7.1

3.5

—

(3006504) Eosinophils/100 leukocytes in Blood

2187

10733

4.43

307.65

14.7

5.1

2.5

2.9

18.66

2138

9848

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1490

3784

6.60

307.65

3.1

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

1075

2572

5.84

307.65

1.6

1.3

573.1

510.3

titre

0.47

309

563

(3009445) Proteinase 3 Ab [Units/volume] in Serum

727

916

10.03

307.65

1.8

1.6

17.4

17.0

u/ml

0.02

(3023419) Bacteria identified in Sputum by Culture

425

187

26.13

307.65

3.1

1.7

—

(3001604) Monocytes [#/volume] in Blood

2282

11456

4.64

307.65

13.7

4.9

0.7

0.6

e9/l

33.39

2099

9665

(3003396) Base excess in Arterial blood by calculation

1050

2864

5.01

307.65

10.1

6.3

1.7

0.7

mmol/l

9.57

881

2180

(3006315) Basophils [#/volume] in Blood

2284

11528

4.61

307.65

13.7

4.9

0.0

e9/l

1.30

2106

9738

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

821

686

15.86

307.65

3.4

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

291

156

20.46

307.65

3.5

3.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

655

351

23.32

307.65

2.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

469

204

26.86

307.65

1.9

1.2

—

(44790049)

331

160

23.01

307.65

2.6

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

249

77.19

307.65

1.9

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

672

363

23.29

307.65

2.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

223

33.27

307.65

2.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

344

280

13.68

307.65

3.6

2.3

—

(3019060) Gas panel - Arterial blood

835

1617

6.67

307.65

5.6

4.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

401

164

27.89

307.65

2.7

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

542

78.73

307.65

2.3

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

457

197

26.98

307.65

2.5

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

2191

10782

4.42

307.65

15.2

5.4

8.8

9.0

2.77

2141

9935

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

425

306

15.91

307.65

11.6

4.4

1894.6

535.8

iu/ml

0.46

101

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

324

257

13.94

307.65

1.2

1.1

—

(44806118)

331

160

23.01

307.65

2.6

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

624

415

18.52

307.65

2.1

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

222

33.57

307.65

2.3

1.2

—

(3022096) Basophils/100 leukocytes in Blood

2176

10436

4.54

307.65

14.5

5.2

0.6

0.7

18.90

2130

9593

(44790047)

331

160

23.01

307.65

2.6

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1206

2545

7.07

307.65

2.9

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1057

2859

5.07

307.65

10.0

6.3

9.8

12.6

kpa

71.19

1014

2731

(3005719) IgG [Mass/volume] in Serum or Plasma

755

1467

6.46

307.65

4.6

2.5

10.0

10.8

g/l

2.86

726

1324

(44790048)

331

160

23.01

307.65

2.6

1.2

—

(42870588) Differential panel, method unspecified - Blood

1880

7929

4.42

307.65

13.5

5.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

526

691

8.94

307.65

2.0

1.5

339.2

186.3

titre

0.70

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

193

32.58

297.79

1.5

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

289

241

13.11

292.44

5.3

2.6

791.2

2798.9

u/ml

0.78

(3028026) IgM [Mass/volume] in Serum or Plasma

591

1174

5.97

291.81

2.3

1.8

1.1

1.5

g/l

3.51

551

1060

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

242

151

17.28

288.01

2.1

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

325

335

10.71

285.60

1.7

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

246

168

15.80

279.20

2.1

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

408

583

7.90

276.67

2.0

1.3

13.7

9.8

iu/ml

—

(3000494) Fungus identified in Specimen by Culture

866

2511

4.38

270.66

2.5

1.4

—

(3016502) Oxygen saturation in Arterial blood

880

2632

4.26

263.05

11.0

6.5

93.2

95.9

18.84

847

2532

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

339

421

8.91

258.21

1.5

1.2

223.5

127.5

titre

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

382

547

7.81

258.10

2.8

2.0

126.4

128.7

g/l

0.61

188

406

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

152

45.59

257.20

1.4

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

573

1266

5.31

249.56

11.1

8.3

24.8

24.0

mmol/l

6.06

534

1173

(3013650) Neutrophils [#/volume] in Blood by Automated count

2322

13546

3.75

238.45

18.5

7.6

5.1

4.1

e9/l

60.28

2174

11638

(3042936) Bacteria identified in Isolate by Culture

976

3347

3.78

237.38

2.8

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

739

2175

4.14

222.49

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

169

20.47

219.69

4.6

2.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

395

708

6.24

214.62

1.3

1.2

1.3

0.6

u/ml

0.48

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

278

339

8.90

214.15

1.6

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

278

339

8.90

214.15

1.6

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

209

172

12.95

212.38

1.4

1.1

—

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

339

527

7.09

211.60

1.9

1.4

0.2

g/l

0.56

324

498

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

170

18.47

210.76

1.2

1.1

—

(1616796) Gas panel - Central venous blood

324

490

7.26

207.38

6.2

3.1

—

(3017181) Myelocytes/100 leukocytes in Blood

664

1927

4.10

202.38

6.8

3.6

0.9

0.03

289

492

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

339

553

6.75

201.93

1.9

1.4

1.2

g/l

1.09

327

521

(3005322) IgE [Units/volume] in Serum or Plasma

453

980

5.23

200.21

1.7

1.2

209.8

216.7

u/ml

0.06

419

900

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

105

77.56

196.02

3.1

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

183

146

13.25

189.31

1.2

1.3

7.8

6.9

g/l

0.87

126

(3024139) IgG subclass 3 [Mass/volume] in Serum

183

146

13.25

189.31

1.2

1.3

0.5

g/l

0.08

126

(3028192) IgG subclass 2 [Mass/volume] in Serum

183

146

13.25

189.31

1.2

1.3

2.8

3.0

g/l

0.37

127

(3024980) IgG subclass 4 [Mass/volume] in Serum

228

254

9.60

188.09

1.6

1.7

0.8

1.0

g/l

0.34

164

198

(3002179) Metamyelocytes/100 leukocytes in Blood

610

1751

4.08

187.82

6.6

3.5

0.5

0.6

0.16

229

352

(4062490)

182

147

13.08

186.85

1.2

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

534

1395

4.41

186.61

11.8

6.3

25.3

24.5

mmol/l

3.74

525

1385

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

177

137

13.63

186.42

1.7

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

177

137

13.63

186.42

1.7

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

177

137

13.63

186.42

1.7

1.4

—

(3011412) CD3 cells [#/volume] in Blood

182

151

12.73

183.77

2.5

2.3

1.0

1.1

e9/l

0.83

134

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

576

1620

4.13

182.08

2.0

1.5

—

(3000492) Spirometry study

596

1734

4.01

179.58

3.0

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

966

3847

3.18

178.38

7.2

2.8

0.8

mmol/l

2.37

899

3555

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

904

3465

3.26

178.08

1.4

1.2

58.8

37.1

iu/ml

2.67

335

1048

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

544

1490

4.21

178.06

6.8

3.3

2.5

1.5

mmol/l

7.14

452

1046

(3009343) pH of Capillary blood

555

1550

4.14

176.84

7.0

3.3

7.4

3.58

110

184

(3002173) Hemoglobin [Mass/volume] in Arterial blood

722

2420

3.58

176.33

12.4

6.7

121.6

120.1

g/l

1.06

699

2334

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2004

11866

2.91

176.22

11.4

5.3

1.2

mmol/l

12.49

1896

10584

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

558

1572

4.10

175.61

7.0

3.3

5.2

5.1

kpa

0.96

531

1434

(3018418) pH of Serum or Plasma

1496

7657

2.82

173.50

6.3

3.5

7.4

0.65

377

1386

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

333

626

5.83

171.14

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2098

12872

2.90

169.74

10.9

5.8

11.2

12.8

umol/l

5.98

2031

12158

(1175426) CD3 cells/100 lymphocytes in Blood

154

110

14.67

169.74

2.4

71.5

69.7

0.41

148

101

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

152

107

14.88

168.89

2.4

16.8

14.9

0.38

(3021440) Promyelocytes/100 leukocytes in Blood

604

1850

3.80

168.34

7.0

3.6

0.1

0.16

273

454

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

147

101

15.22

165.50

2.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

124

21.12

164.05

2.2

1.8

67932.1

67676.3

u/ml

—

(3027315) Oxygen [Partial pressure] in Blood

287

498

6.24

160.05

8.3

3.5

8.0

8.5

kpa

5.66

279

487

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

249

374

7.15

159.64

5.4

3.3

61.1

57.7

2.70

249

374

(3020779) Urea [Moles/volume] in Serum or Plasma

668

2267

3.47

158.61

12.4

6.1

11.4

10.7

mmol/l

1.61

635

2132

(3013290) Carbon dioxide [Partial pressure] in Blood

285

496

6.22

158.43

8.3

3.5

5.0

4.9

kpa

1.38

277

485

(3012501) Base excess in Blood by calculation

285

496

6.22

158.43

8.3

3.5

3.0

2.5

mmol/l

1.63

222

305

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2094

13129

2.79

157.04

12.5

5.9

1.2

mmol/l

5.42

1758

10997

(4010399)

543

1619

3.85

156.70

2.2

1.4

—

(3010421) pH of Blood

309

589

5.71

156.14

8.1

3.5

7.4

0.42

277

486

(3015235) Bicarbonate [Moles/volume] in Capillary blood

317

627

5.51

153.80

5.7

2.7

25.6

24.6

mmol/l

2.66

292

543

(3028626) Oxygen [Partial pressure] in Capillary blood

298

558

5.80

153.42

6.4

3.2

7.6

8.2

kpa

7.66

286

516

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

833

3293

3.08

152.85

1.3

1.2

33.0

13.4

u/ml

2.02

258

1182

(3025159) Blasts/100 leukocytes in Blood

562

1746

3.70

152.41

7.0

3.6

0.1

0.4

0.89

241

390

(40767503) Oxygen content in Capillary blood by calculation

283

518

5.91

149.16

4.0

2.0

15.5

16.2

1.55

158

270

(3021901) Oxygen saturation in Capillary blood

264

453

6.27

148.70

5.4

2.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1050

4790

2.79

147.16

2.8

1.7

1.8

1.4

mg/l

1.40

901

3686

(21494815) CD4 cells/100 lymphocytes in Specimen

145

123

12.31

144.11

2.4

2.3

32.7

47.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1564

8755

2.57

143.59

4.7

2.9

2181.1

1574.3

ng/l

5.00

1433

7550

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

368

875

4.63

143.54

1.7

37.2

39.0

u/l

0.82

331

744

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

254

437

6.24

142.58

1.3

1.2

8.3

6.9

u/ml

0.10

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

277

519

5.76

142.30

1.4

1.2

16.7

3.9

u/ml

0.74

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

278

525

5.71

141.60

1.4

1.2

13.8

6.9

u/ml

0.69

(3000991) Gas panel - Venous blood

606

2081

3.37

139.87

12.1

6.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

282

552

5.51

138.08

1.4

1.2

39.9

34.6

u/ml

0.10

(3001964) Herpes simplex virus Ag [Presence] in Specimen

25.36

136.84

2.9

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

301

630

5.18

136.65

1.8

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

213

324

6.98

134.65

1.4

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

558

1861

3.43

134.61

2.1

342.4

379.3

nmol/l

2.59

521

1697

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

464

1378

3.78

133.56

1.8

1.3

—

(3026782) Osmolality of Urine

1071

5154

2.64

132.61

4.3

2.7

530.3

558.1

mosm/kgh2o

4.87

974

4346

(3014111) Lactate [Moles/volume] in Serum or Plasma

608

2192

3.20

128.71

11.3

6.0

1.5

1.4

mmol/l

1.70

580

2114

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

264

519

5.46

128.48

1.8

1.9

11.2

11.4

mg/l

0.15

244

469

(40760892) CBC W Ordered Manual Differential panel - Blood

989

4641

2.65

128.20

10.4

4.1

—

(3002582) Erythrocytes [#/volume] in Urine

1423

7931

2.45

127.62

5.6

3.3

121.5

90.7

e6/l

0.15

1197

6121

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

745

3027

2.92

127.61

4.9

3.8

274.0

246.1

u/l

3.51

709

2829

(3000850) Epithelial cells [#/volume] in Urine

1112

5534

2.56

127.50

4.2

2.5

4.9

4.5

e6/l

0.48

1029

4846

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

196

290

7.14

127.04

1.4

145.5

128.2

u/ml

0.19

(3008152) Bicarbonate [Moles/volume] in Arterial blood

505

1638

3.48

126.85

10.6

6.0

25.3

24.2

mmol/l

7.87

481

1523

(40757373) Influenza virus identified in Isolate

29.73

126.57

2.7

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

772

3226

2.85

125.24

8.8

4.9

1.1

1.0

mmol/l

1.73

715

2972

(36304419) Bacteria [Presence] in Urine

1295

6964

2.46

125.10

5.2

3.1

—

(3002032) Base excess in Venous blood by calculation

641

2431

3.06

123.99

5.3

3.2

2.5

1.7

mmol/l

5.13

533

1935

(3021589) Normoblasts [#/volume] in Blood

1690

10262

2.40

123.75

23.1

9.1

0.0

e9/l

0.28

1470

8370

(40758558) Short blood count panel - Blood

1134

5773

2.51

123.05

13.1

5.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

100

17.78

122.56

46.3

22.8

156.3

116.5

ug/l

2.96

(3021447) Carbon dioxide [Partial pressure] in Venous blood

635

2441

3.01

119.56

5.3

3.2

6.0

5.8

kpa

3.94

606

2374

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

20.14

119.51

2.2

2.5

—

(3012544) pH of Venous blood

648

2525

2.97

119.03

5.3

3.2

7.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

263

551

5.12

118.93

1.6

13.5

16.2

iu/ml

0.06

108

(3030467) Casts [#/volume] in Urine by Automated count

1311

7248

2.39

117.18

5.3

3.1

0.4

0.5

e6/l

0.74

1086

5506

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

267

574

4.99

117.12

3.4

2.5

4.0

3.4

g/l

5.00

259

543

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1284

7059

2.39

115.96

5.7

2.9

35.1

36.1

u/l

0.16

1233

6651

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

108

13.77

115.49

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

108

13.77

115.49

1.8

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

108

13.77

115.49

1.8

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

822

3721

2.64

112.60

2.1

1.4

2.8

2.6

g/l

1.13

614

2112

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

631

2495

2.91

112.30

5.0

2.8

266.3

216.0

ng/l

1.96

591

2280

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

106

13.51

112.10

1.8

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1771

11275

2.31

112.09

7.4

4.3

32.4

35.2

g/l

69.18

1656

10385

(3024891) Influenza virus A+B Ag [Presence] in Specimen

201

347

6.12

112.07

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

24.53

111.30

4.3

4.0

—

(3018095) Leukocytes [#/volume] in Urine

1514

9049

2.30

111.17

6.7

3.7

86.4

106.3

e6/l

0.26

1228

6573

(3017143) Hepatitis C virus Ab [Presence] in Serum

509

1797

3.19

110.51

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

16.21

108.93

2.2

2.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

331

891

4.04

108.75

4.2

2.9

0.3

u/ml

0.94

201

508

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

786

3552

2.62

107.43

3.2

2.4

19.5

22.7

9.46

663

2989

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

15.43

106.13

1.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

15.43

106.13

1.8

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

15.43

106.13

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

425

1384

3.40

105.09

15.4

8.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

811

3781

2.54

103.40

3.1

2.3

2.2

2.3

g/l

4.99

753

3472

(3032080) INR in Blood by Coagulation assay

1749

11321

2.23

103.03

14.9

10.0

1.3

inr

1.34

608

3013

(3021879) Hepatitis B virus core Ab [Presence] in Serum

375

1143

3.59

102.70

1.4

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

850

4079

2.49

101.64

3.2

2.3

10.5

12.9

umol/l

21.47

801

3746

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

524

1972

2.99

101.25

1.6

1.5

—

(3028433) Virus identified in Specimen by Culture

15.24

100.93

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2414

17969

2.49

100.37

10.6

3.9

20.6

12.9

mm/h

73.33

2348

16346

(3014576) Chloride [Moles/volume] in Serum or Plasma

735

3338

2.57

98.46

12.9

5.8

103.5

104.6

mmol/l

6.11

711

3268

(3013826) Glucose [Moles/volume] in Serum or Plasma

2130

15119

2.27

97.42

10.4

4.2

6.9

6.8

mmol/l

1.47

2056

14197

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

104

11.05

96.93

1.5

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

985

5155

2.33

96.03

5.8

3.7

427.3

631.7

ng/l

0.51

890

4403

(3022313) Gas panel - Capillary blood

360

1135

3.45

93.25

7.4

3.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

364

1160

3.42

92.69

4.9

3.4

24.6

23.9

mmol/l

3.22

334

1021

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

107

111

9.94

92.55

2.4

2.1

491.0

468.9

e6/l

0.15

(3008536) Aspergillus sp Ab [Presence] in Serum

25.11

90.98

1.8

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

558

2294

2.74

90.73

2.2

65.3

66.5

g/l

2.85

517

2047

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

441

1598

3.05

90.56

2.2

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

128

176

7.54

88.36

1.5

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

148

239

6.45

88.02

1.3

1.2

70.0

41.4

u/ml

0.52

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

10.98

87.35

1.7

1.2

1.9

1.8

u/ml

0.02

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

238

594

4.25

86.18

3.6

2.4

90.6

87.7

1.05

227

560

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

104

9.80

84.81

2.6

2.1

0.2

e9/l

0.08

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

155

272

5.94

84.77

1.2

358.3

254.2

u/ml

2.58

101

160

(3004588) Protein electrophoresis panel - Serum or Plasma

491

1961

2.78

83.99

2.0

—

(3024932) HLA-DR beta [Type]

16.12

83.08

1.0

1.1

—

(3024471) HLA-A [Type]

15.66

82.97

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

180

370

5.10

82.80

1.4

1.2

63.1

48.7

u/ml

0.44

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

160

298

5.60

82.15

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

13.58

81.99

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

13.58

81.99

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

13.58

81.99

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

13.58

81.99

1.1

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2461

19143

2.33

81.56

16.4

6.9

79.9

80.8

u/l

0.42

2408

17823

(3023420) DNA double strand Ab [Units/volume] in Serum

123

179

7.11

80.67

2.2

1.2

20.0

27.6

iu/ml

—

(3033658) Prothrombin time (PT) actual/Normal

1068

6164

2.11

78.66

7.1

3.7

84.3

85.1

0.39

1047

6010

(3048929) Epstein Barr virus Ab [Presence] in Serum

182

397

4.81

78.02

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

690

3350

2.36

77.85

4.0

2.2

2.0

1.7

6.66

617

2900

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

137

7.90

75.79

1.3

1.2

164.5

113.2

titre

0.32

(3031040) Bacteria [#/volume] in Urine by Automated count

2187

16490

2.08

74.57

7.2

4.6

727.6

2224.4

e6/l

1.37

262

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

211

540

4.12

73.71

3.7

2.5

227.2

198.0

3.73

200

510

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

414

1630

2.77

72.19

15.4

7.6

0.7

0.31

408

1618

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

414

1646

2.75

70.77

15.3

7.5

1.4

1.3

2.06

408

1634

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

9.66

70.58

2.4

2.8

37.9

35.6

0.28

(3004809) Band form neutrophils/100 leukocytes in Blood

165

362

4.76

70.17

4.5

3.3

1.7

1.3

0.57

144

264

(3037467) Urinalysis macro (dipstick) panel - Urine

2216

16977

2.04

69.69

7.6

4.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

476

2059

2.55

68.52

4.4

2.7

4.4

kpa

0.03

454

2000

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

137

263

5.40

67.98

1.4

1.2

6.9

2.8

u/ml

0.42

(3018677) aPTT in Platelet poor plasma by Coagulation assay

775

4154

2.15

67.60

3.1

1.9

29.9

30.0

0.28

755

4015

(3007853) Bacteria identified in Skin by Aerobe culture

566

2668

2.37

67.42

2.3

1.7

—

(3047181) Lactate [Moles/volume] in Blood

248

761

3.45

66.43

10.2

5.6

1.4

1.3

mmol/l

0.99

225

675

(3004616) Nuclear Ab [Presence] in Serum

139

276

5.22

66.42

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

132

251

5.45

66.18

1.4

1.2

2.4

4.6

u/ml

1.35

108

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

510

2322

2.43

65.54

2.2

2.1

0.2

g/l

0.02

471

2160

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1112

6873

1.96

64.99

2.7

2.2

3.4

3.1

mg/l

3.17

988

5750

(3017569) Oxygen content in Arterial blood

120

7.69

63.74

2.3

1.9

—

(4306422)

128

245

5.40

63.70

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

7.78

62.93

2.5

1.9

723.8

624.9

e6/l

0.50

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

307

1106

2.97

62.79

7.5

4.5

1.8

1.6

2.91

287

1043

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

556

2677

2.31

62.69

5.6

3.2

—

(3036489) Thrombin time

247

789

3.31

61.99

3.5

2.0

21.7

21.8

0.04

225

707

(3019977) pH of Arterial blood

133

7.18

61.91

2.8

2.2

7.4

0.11

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

763

4188

2.09

61.79

4.6

3.0

1.9

2.0

e6/l

0.26

443

2355

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

149

6.76

61.66

2.3

2.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

228

695

3.46

61.63

1.5

1.2

—

(4015189)

12.72

61.56

2.7

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

144

6.85

61.17

1.1

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1441

9836

1.86

61.02

3.0

2.1

77.7

79.3

nmol/l

1.32

1323

8543

(3006245) CD3-CD19+ cells/100 cells in Blood

12.46

60.79

2.6

2.4

9.9

14.1

0.64

(3026493) Urate [Moles/volume] in Serum or Plasma

1066

6657

1.91

59.20

5.6

2.6

2499.0

7067.1

umol/l

4.25

941

5606

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1480

10258

1.84

59.01

6.2

3.8

152.7

55.2

ng/l

0.42

1236

7870

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

104

176

6.08

58.94

1.2

1.1

49.5

2.6

u/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

334

1310

2.73

58.15

1.9

1.5

1.7

1.5

g/l

3.38

285

1100

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

106

187

5.83

57.56

1.2

1.1

31.2

63.2

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

158

393

4.18

57.21

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

25.31

56.95

1.4

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

121

244

5.12

56.78

1.3

1.1

118.1

114.7

0.43

116

218

(3007930) Methemoglobin/Hemoglobin.total in Blood

291

1091

2.84

55.13

7.9

4.6

0.8

0.9

0.51

271

1030

(3037756) Immunofixation for Serum or Plasma

196

583

3.52

54.94

1.4

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1304

8835

1.81

54.78

4.7

3.1

2.3

2.4

mmol/l

6.61

1169

7515

(3038026) Centromere Ab [Units/volume] in Serum

106

196

5.56

54.76

1.2

1.1

32.3

64.0

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

13.20

54.58

1.4

1.6

—

(3039000) Anion gap in Blood

189

556

3.55

53.87

10.3

6.4

11.8

11.3

mmol/l

0.90

172

500

(3018572) Chloride [Moles/volume] in Blood

189

556

3.55

53.87

10.3

6.4

103.7

105.5

mmol/l

5.98

172

500

(3014148) Varicella zoster virus Ab [Titer] in Serum

154

6.19

53.86

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

520

2582

2.22

53.79

3.9

2.2

75.0

67.2

e9/l

3.74

373

1964

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1566

11269

1.78

53.10

3.3

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

118

247

4.92

53.01

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1383

9626

1.78

52.34

3.7

2.7

230.3

148.3

ug/l

9.12

1281

8688

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

458

2183

2.29

52.21

5.9

3.4

1.2

mmol/l

3.56

433

1868

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1204

8058

1.80

51.96

3.8

2.1

166.1

210.8

u/l

1.14

1140

7510

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

404

3.96

51.84

1.1

—

(3026008) Bacteria identified in Urine by Culture

1195

7985

1.80

51.81

4.0

3.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

127

6.60

50.69

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

127

6.60

50.69

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

127

6.60

50.69

1.3

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

164

457

3.73

50.65

2.0

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

108

218

5.10

50.61

1.5

1.4

6.6

6.2

mmol/l

0.51

206

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

514

2605

2.16

50.25

3.1

2.5

8.9

9.8

umol/l

0.38

447

2292

(3020891) Body temperature

273

1041

2.78

49.97

6.9

4.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

184

5.47

49.79

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

25.27

49.75

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

130

6.45

49.56

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

130

6.45

49.56

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

130

6.45

49.56

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

239

855

2.94

49.23

3.6

2.1

361.8

792.3

ug/l

1.04

229

814

(3035350) Ketones [Presence] in Urine by Test strip

1605

11815

1.73

48.64

5.4

3.7

0.0

estimate

0.00

466

2153

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1137

7634

1.77

47.46

3.1

2.4

61.9

60.1

u/l

0.13

1062

6971

(4268621)

174

5.48

47.43

2.4

2.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

195

5.16

46.68

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

210

721

3.05

46.48

4.8

3.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

7.00

45.80

1.1

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1610

11996

1.70

45.52

5.5

3.8

0.0

estimate

1.08

456

2093

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

201

5.00

45.08

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

1591

11837

1.70

45.05

7.3

5.0

0.0

estimate

0.50

472

2155

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

753

4524

1.87

44.99

4.3

2.8

0.9

1.3

e6/l

2.28

434

2660

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

255

992

2.71

44.80

8.8

3.6

25.3

24.6

mmol/l

3.73

246

892

(3003434) Protein [Mass/volume] in Pleural fluid

129

333

4.00

44.38

1.6

1.5

32.2

30.8

g/l

0.54

114

307

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

171

5.33

44.09

1.3

15.7

12.8

u/l

0.48

162

(4035726)

432

2152

2.17

43.73

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1023

2.65

43.11

2.3

1.9

10.6

10.2

g/l

0.63

219

852

(3034860) Kappa light chains.free [Mass/volume] in Serum

236

900

2.75

43.06

2.6

2.7

63.7

117.8

mg/l

0.41

167

739

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

102

226

4.63

42.80

1.4

1.3

503.0

302.6

u/l

1.71

214

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

234

897

2.74

42.26

2.6

2.7

50.7

64.2

mg/l

0.38

164

741

(40761536) Microorganisms panel - Urine sediment

406

2001

2.18

42.13

6.0

3.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

266

1090

2.57

42.04

2.2

1.9

3.8

g/l

0.06

204

758

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

266

1091

2.57

41.96

2.2

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

266

1091

2.57

41.96

2.2

1.9

8.0

7.3

g/l

5.55

208

790

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

252

1009

2.63

41.75

2.3

2.0

3.4

3.0

g/l

5.21

207

781

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

229

875

2.74

41.60

2.6

2.7

3.6

2.3

ratio

0.38

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

254

1029

2.60

41.07

3.0

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

304

1350

2.39

40.36

5.5

2.9

25.8

25.0

mmol/l

3.14

283

1309

(3018405) Lactate [Moles/volume] in Arterial blood

235

928

2.66

40.00

5.6

3.4

1.4

mmol/l

0.01

230

914

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

214

808

2.77

39.75

2.2

1.9

0.1

0.0

g/l

0.27

199

730

(3034426) Prothrombin time (PT)

8.74

39.65

1.1

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

353

1688

2.23

39.36

5.7

2.9

123.8

128.2

g/l

3.25

338

1644

(3015736) pH of Urine

1273

9193

1.65

38.36

4.5

3.5

—

5.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

251

4.21

38.30

5.3

3.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

200

750

2.78

37.62

2.2

1.9

0.0

g/l

0.50

185

676

(3012441) Differential panel - Pleural fluid

103

256

4.13

37.31

1.7

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

217

854

2.66

37.15

2.2

1.9

35.5

37.9

g/l

6.09

196

710

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

110

288

3.92

37.11

8.8

6.8

12.0

12.3

mg/l

0.27

101

269

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

230

932

2.58

37.11

2.2

2.1

0.6

1.1

g/l

1.45

205

783

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

196

736

2.77

36.76

2.2

2.0

0.0

g/l

0.00

185

674

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

6.33

36.40

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

184

673

2.84

36.26

2.6

2.9

—

(3025941) Bacteria identified in Stool by Culture

249

1061

2.46

36.12

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

229

4.25

35.84

1.7

1.4

—

(3021788) Differential panel - Synovial fluid

137

435

3.25

34.55

1.7

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

108

294

3.77

34.49

1.7

1.4

5865.6

1621.5

e6/l

0.70

216

(3023183) Ammonium ion [Moles/volume] in Plasma

144

472

3.15

34.44

2.6

2.5

33.0

34.7

umol/l

0.38

125

385

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

121

5.29

31.25

2.2

1.6

6.3

6.9

u/l

0.23

108

(3035880) pH of Pleural fluid

125

5.21

31.16

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2226

18893

1.61

31.12

47.2

17.9

14.6

13.8

90.87

2203

18415

(3046861) Legionella sp Ag [Presence] in Urine

60.66

31.09

1.1

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

843

5738

1.64

30.59

2.0

1.8

1210.1

1155.4

nmol/l

0.81

642

4227

(3028308) Erythrocytes [#/volume] in Pleural fluid

270

3.68

30.01

1.6

1.3

104212.1

102068.4

e6/l

0.01

156

(40768806) Pleura Pathology biopsy report

262

3.71

29.79

1.7

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

133

454

3.01

29.68

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

386

2114

1.94

29.53

2.8

2.3

35.5

39.8

u/l

0.76

354

1815

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

156

583

2.76

29.50

3.8

2.8

1.8

1.6

mg/l

2.26

144

514

(3000060) B lymphocytes [#/volume] in Blood

9.54

28.85

2.9

2.2

1268.3

388.0

e6/l

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

218

969

2.34

28.69

2.6

1.6

—

(3051651) Icteric interference index of Serum or Plasma

123

4.95

27.67

6.5

3.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

264

1290

2.14

27.60

4.7

2.4

1.3

1.1

3.37

264

1281

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

168

683

2.54

26.86

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.58

26.64

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

872

6157

1.58

26.51

5.7

3.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.22

26.50

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

109

5.12

26.37

4.2

3.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

10.44

26.24

1.6

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

6.85

25.89

2.4

2.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

354

1965

1.90

25.86

4.5

3.4

107.0

90.5

ng/l

2.02

306

1660

(3004451) EKG impression Narrative

135

4.59

25.69

1.4

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

12.59

25.48

1.4

1.1

90.7

22.9

ng/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

137

4.52

25.23

1.8

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

9.17

24.73

1.6

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

18.29

24.73

1.2

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

901

6523

1.53

24.06

6.1

4.1

0.0

estimate

0.88

431

2047

(3040151) Glucose [Moles/volume] in Capillary blood

292

3.25

23.93

17.6

6.6

7.6

7.5

mmol/l

0.09

236

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

734

5103

1.57

23.40

3.1

2.9

2.5

mmol/l

10.50

650

4468

(3043409) Potassium [Moles/volume] in Arterial blood

179

801

2.31

23.16

6.8

3.6

4.0

3.9

mmol/l

0.81

159

748

(40768446) Kidney Pathology biopsy report

6.40

23.08

1.4

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

308

3.12

22.55

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

159

684

2.40

22.51

1.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

795

5680

1.54

22.27

4.5

3.7

—

(3045716) Anion gap in Serum or Plasma

118

4.55

22.18

2.4

2.2

8.1

9.5

mmol/l

1.85

(3024928) Oxygen saturation in Venous blood

131

519

2.59

22.10

4.4

2.8

—

(3045142) Bone marrow Pathology biopsy report

283

3.17

21.79

1.4

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

148

628

2.42

21.60

3.0

0.9

0.8

nmol/l

0.87

122

470

(3016650) Hepatitis A virus Ab [Presence] in Serum

267

3.21

21.22

1.1

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2605

23680

1.59

20.46

45.2

13.8

30.6

24.6

mg/l

21.03

2516

18856

(3042111) Morphology [Interpretation] in Bone marrow Narrative

117

458

2.61

20.25

1.6

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1685

14099

1.42

20.19

4.8

3.0

70.4

53.2

u/l

5.67

1568

12780

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

332

1952

1.78

19.97

1.6

1.7

1.5

2.24

287

1670

(3006576) Bicarbonate [Moles/volume] in Blood

5.40

19.95

6.0

7.3

24.6

24.7

mmol/l

0.04

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.03

19.93

1.7

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

274

3.08

19.70

1.1

1.7

1.5

g/l

1.32

250

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

308

2.94

19.46

1.1

1.3

171.3

211.3

miu/ml

—

113

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

304

2.95

19.30

1.3

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

213

3.34

19.00

1.1

1.2

55.2

64.4

u/l

0.55

139

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

8.12

18.76

1.3

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

136

598

2.33

18.35

1.7

1.6

15831.5

13961.7

e6/l

0.12

101

429

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

10.59

18.22

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

496

3320

1.59

18.14

1.3

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

4.86

17.77

1.4

1.3

3.3

3.6

mmol/l

0.25

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

348

2.72

17.62

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

5.45

17.59

1.1

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

100

391

2.61

17.38

3.0

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

152

3.67

17.30

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

400

2573

1.64

17.19

2.9

2.3

10.7

7.3

ug/l

2.16

342

2198

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

4.38

16.85

1.1

ratio

0.08

(3018851) Theophylline [Moles/volume] in Serum or Plasma

13.40

16.80

2.1

1.5

44.3

36.7

umol/l

0.53

(3003327) Ova and parasites identified in Stool by Light microscopy

129

577

2.29

16.75

2.0

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

295

2.83

16.75

1.8

1.5

59.0

63.5

0.43

188

(3022217) INR in Platelet poor plasma by Coagulation assay

567

3981

1.52

16.62

30.8

28.5

1.5

inr

0.42

543

(3026389) Candida sp identified in Specimen by Organism specific culture

292

2.82

16.49

1.5

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

6.55

16.19

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.90

16.14

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

236

3.01

16.08

5.6

3.2

54.4

57.5

0.48

139

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

12.37

16.03

1.1

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

114

497

2.34

15.72

1.5

1.3

—

(3044941) Cell count panel - Synovial fluid

388

2.52

15.62

1.8

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

219

3.06

15.59

2.0

1.4

34.8

24.4

1.23

141

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1129

9097

1.38

15.46

5.9

4.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

142

686

2.12

15.27

1.4

1.5

275.0

268.4

ug/g

0.14

424

(3044889) 12 lead EKG panel

1982

17459

1.37

15.21

6.4

4.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

118

530

2.27

15.20

1.3

1.1

150.8

76.4

titre

0.85

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

229

2.97

15.04

2.7

2.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

4.63

14.69

1.1

17.0

10.6

u/ml

—

(3044640) Blood type and Crossmatch panel - Blood

1001

7972

1.38

14.51

3.6

2.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

9.49

14.33

1.6

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

9.49

14.33

1.6

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

9.49

14.33

1.6

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1373

11501

1.34

14.30

5.8

4.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

594

4335

1.46

14.15

1.3

1.2

1.0

1.7

u/ml

1.98

150

1096

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

311

2.61

14.13

1.7

28.9

27.4

ug/l

0.06

304

(40768795) Lymph node Pathology biopsy report

211

2.98

14.05

1.3

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

155

3.33

13.95

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

108

3.83

13.86

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

108

3.83

13.86

1.6

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

157

3.29

13.67

1.6

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

265

2.72

13.59

6.3

3.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

255

2.74

13.47

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.13

13.15

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

187

3.03

13.13

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

7.35

13.12

1.4

1.2

74.1

78.7

0.23

(3029075) Extractable nuclear Ab panel - Serum

4.79

13.06

1.1

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.62

12.88

5.2

2.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

100

3.83

12.88

7.9

7.3

60.6

74.1

mg/l

0.58

(3034891) Synovial lining cells/100 cells in Synovial fluid

110

3.67

12.74

1.9

1.4

2.9

3.1

0.05

(3032743) Legionella sp IgG Ab [Presence] in Serum

20.11

12.44

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

20.11

12.44

1.2

1.0

—

(3003181) Sodium [Moles/volume] in Urine

425

2.27

12.41

1.3

68.3

61.8

mmol/l

0.79

346

(3017732) Neutrophils [#/volume] in Blood

250

1548

1.67

12.38

3.6

3.0

4.8

4.1

e9/l

3.87

196

1088

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

297

2.53

12.29

1.6

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

298

2.52

12.21

1.6

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

298

2.52

12.21

1.6

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

299

2.51

12.12

1.6

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

766

5988

1.37

12.06

1.8

1.7

55161786.8

29558603.3

pmol/l

0.36

620

4821

(3024522) Salmonella sp identified in Specimen by Organism specific culture

300

2.50

12.04

1.6

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

349

2359

1.54

11.98

1.5

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

6.59

11.91

1.5

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

302

2.49

11.88

1.6

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

335

2250

1.55

11.83

2.5

2.1

208.9

150.2

ug/g

1.44

281

1752

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

4.36

11.68

1.4

1.3

25.0

21.9

0.18

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

3.75

11.55

1.5

53.1

72.2

1.63

(3013005) Retinol [Moles/volume] in Serum or Plasma

4.41

11.44

2.7

1.7

1.9

2.0

umol/l

0.36

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

4.14

11.32

1.1

2.1

230.5

172.9

1.23

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.88

11.10

1.5

1.8

1.9

0.07

(3019832) Treponema pallidum Ab [Presence] in Serum

146

799

1.87

11.09

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

132

3.21

10.95

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

132

3.21

10.95

1.6

1.5

—

(44806071)

8.27

10.61

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

301

2.39

10.54

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

115

3.33

10.53

2.6

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

853

6906

1.32

10.38

1.9

1.6

19.0

20.1

nmol/l

1.21

773

5785

(3017704) Immunofixation for Urine

153

2.97

10.30

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

6.33

10.27

1.6

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

11.04

10.16

1.5

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

210

2.65

10.16

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

1149

9719

1.29

10.01

2.5

2.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.46

10.01

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.46

10.01

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.00

9.76

1.3

1.1

—

(3000012) Reticulocyte production index

153

2.90

9.70

2.2

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

5.89

9.59

1.0

1.1

100.3

81.0

—

(3052592) Norovirus Ag [Presence] in Stool

4.80

9.53

2.0

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

104

3.29

9.30

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

231

3437

0.65

9.23

4.6

4.8

32.5

33.2

0.36

154

2192

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

180

2.69

9.22

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

131

3.00

9.15

1.5

1.6

8.6

6.1

u/l

0.40

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.59

9.05

1.3

1.2

1.8

1.5

mmol/l

0.66

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.51

8.97

1.4

1.2

417.4

1075.0

u/l

0.26

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

758

6148

1.31

8.89

3.3

2.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.34

8.86

1.0

1.4

98.1

84.4

0.75

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.61

8.82

4.0

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.61

8.82

4.0

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.67

8.71

1.2

1.3

136.4

909.2

ug/l

0.88

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

174

2.67

8.70

1.4

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.62

8.55

3.2

2.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

6.39

8.52

1.4

1.2

134.0

139.6

ug/l

—

(3044927) Protein electrophoresis panel - Urine

318

2.20

8.50

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

5.54

8.49

1.0

1.1

83.8

80.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

114

633

1.83

8.35

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

173

2.62

8.26

1.3

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

113

629

1.83

8.22

1.3

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

5.36

8.20

1.3

1.4

25.9

14.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

2215

20532

1.27

8.16

41.8

16.1

37.9

38.8

3.80

1397

12876

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

396

2949

1.39

8.14

3.0

3.9

12.3

25.5

ug/l

1.17

324

2445

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

9.12

8.08

2.4

1.9

4.1

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.08

7.99

1.9

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.14

7.99

1.0

1.1

95.3

84.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

154

2.68

7.89

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

173

2.57

7.75

1.3

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.88

7.69

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.54

7.69

3.4

1.6

149.1

89.5

umol/l

0.56

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.34

7.68

1.4

1.5

4.3

4.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

110

623

1.79

7.59

1.3

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1310

11527

1.23

7.47

2.3

2.1

90.8

93.7

pmol/l

1.40

707

5958

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.55

7.41

5.8

7.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

255

3556

0.69

7.26

11.9

7.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

100

558

1.82

7.26

1.3

1.2

—

(40768443) Skin Pathology biopsy report

174

1130

1.57

7.17

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.90

7.15

4.7

7.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

221

1515

1.49

7.10

2.4

2.5

—

(3014891) Appearance of Pleural fluid

5.20

6.97

2.1

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.59

6.93

1.3

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

278

2004

1.42

6.88

4.1

2.7

54.2

60.9

ml/min/173m2

2.35

133

851

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1911

17576

1.22

6.81

3.9

3.8

15.0

pmol/l

0.46

1715

15545

(3017817) Protein [Mass] in Urine collected for unspecified duration

210

2.31

6.76

1.5

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

16.72

6.74

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.05

6.61

1.4

1.2

—

(3024263) Appearance of Synovial fluid

129

2.65

6.47

1.9

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

4.84

6.45

1.0

1.3

10.9

5.1

nmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.74

6.36

1.2

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.47

6.28

1.2

1.3

19.0

24.1

u/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.52

6.15

1.4

1.2

9.3

9.8

ug/l

0.21

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.12

6.08

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

219

1547

1.45

6.07

1.2

—

(3012565) Volume of 24 hour Urine

106

2.75

5.95

1.8

2.5

1952.5

2018.6

0.12

(3016750) Collection duration of Urine

160

2.39

5.87

1.6

1.9

456.6

495.3

min

0.89

121

(21494890) Protein electrophoresis panel - 24 hour Urine

277

2.04

5.87

1.5

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

973

8495

1.21

5.57

3.6

3.1

6.9

7.3

mmol/l

2.51

797

7003

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.25

5.52

1.0

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.96

5.44

1.4

1.2

0.5

3.4

mmol/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

16.04

5.41

1.4

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

16.04

5.41

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

16.04

5.41

1.1

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

112

2.60

5.38

1.1

88.0

91.4

u/l

0.08

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1216

0.57

5.35

1.9

1.8

—

(3036603) Volume of Urine

149

2.36

5.31

1.4

1531.3

1763.7

0.54

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

113

2.58

5.29

1.1

28.2

33.7

u/l

0.20

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.01

5.26

14.0

8.8

5.8

mmol/l

0.03

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.01

5.26

1.0

—

(21494434) Karyotype in Bone marrow

241

2.05

5.25

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.76

5.20

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

165

2.26

5.07

3.2

2.1

—

(3012516) Albumin [Mass/volume] in Urine

949

8342

1.20

4.94

3.7

3.2

743.5

270.9

mg/l

1.76

659

5280

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

819

9365

0.83

4.90

4.0

4.8

21.4

22.2

0.72

365

5054

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

188

2.14

4.84

1.8

1.9

148.0

1065.9

u/l

1.04

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.30

4.82

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

460

1.71

4.81

1.3

1.2

41.0

26.7

u/l

0.73

398

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2288

23967

0.83

4.80

5.1

5.4

2.5

2.6

mmol/l

10.04

2030

21591

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.08

4.79

1.7

1.5

0.3

0.4

ug/l

0.51

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2224

23345

0.84

4.71

4.7

4.4

4.5

mmol/l

4.30

1961

21126

(3037121) Protein [Mass/volume] in Urine

136

926

1.49

4.62

3.3

2.9

0.4

0.3

g/l

0.87

370

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

159

2.21

4.62

1.3

1.1

—

(21494755) Public health laboratory ask at order entry panel

1014

0.56

4.58

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.06

4.51

5.2

8.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

159

1124

1.44

4.47

2.7

3.2

4.2

4.4

pmol/l

2.66

133

968

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

774

0.51

4.45

1.7

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

149

2.23

4.43

1.7

1.8

0.8

2.0

u/field

2.11

104

(40761511) CBC panel - Blood by Automated count

2532

24316

1.21

4.37

33.9

14.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

11.69

4.27

1.7

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2206

23111

0.85

4.25

4.6

4.7

1.4

mmol/l

1.75

1944

20771

(3020682) Albumin/Creatinine [Ratio] in Urine

988

8812

1.18

4.22

4.5

3.9

15.1

8.1

mg/mmol

3.11

658

5558

(3047189) Immunofixation for 24 hour Urine

133

2.27

4.22

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

571

6669

0.82

4.17

2.7

3.3

0.7

0.8

ug/l

1.35

406

4783

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.20

4.05

1.2

1.1

0.9

0.8

mg/l

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

142

2.19

4.05

1.5

1.3

1.0

promille

0.53

106

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.02

4.01

1.7

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.02

4.01

1.9

5.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.44

3.98

1.0

—

(3001729) Color of Synovial fluid

3.94

3.97

2.1

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

124

2.27

3.96

1.6

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

124

2.27

3.96

1.6

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

399

1.67

3.79

1.3

1.4

—

(3011648) Oxygen content in Venous blood

194

1.97

3.77

8.9

2.7

10.0

10.8

0.59

194

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

202

1.94

3.72

1.2

1.1

2.4

1.3

u/ml

0.26

(1761868) Lipid panel - Serum or Plasma

612

7035

0.84

3.71

3.3

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.95

3.57

2.1

1.5

—

(3008295) Osmolality of Serum or Plasma

228

1.85

3.50

1.4

266.7

277.3

mosm/kgh2o

2.74

168

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

6.17

3.50

1.5

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

456

1.59

3.47

1.1

1.2

3.8

3.9

mmol/l

0.18

419

(3019550) Sodium [Moles/volume] in Serum or Plasma

2597

25130

1.19

3.46

45.2

17.4

138.9

139.7

mmol/l

41.50

2557

24434

(3004716) Salmonella sp identified in Stool by Organism specific culture

120

849

1.43

3.43

1.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

237

1.83

3.43

1.8

2.1

558.8

632.1

0.53

150

(3010144) Erythrocytes [#/volume] in Synovial fluid

246

1.80

3.36

1.6

1.3

171319.5

114911.3

e6/l

0.20

172

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.33

3.33

1.4

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

218

1.85

3.31

2.0

1.9

0.6

0.8

g/24h

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2599

25177

1.19

3.28

45.5

17.6

4.0

mmol/l

1.31

2556

24447

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2259

21645

1.16

3.28

5.0

4.6

2.1

2.0

mu/l

0.54

2053

19295

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.58

3.26

1.3

2.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.58

3.21

1.6

2.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

580

0.53

3.19

1.9

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

178

1.92

3.19

1.1

6.6

4.3

u/ml

0.30

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

111

2.17

3.12

1.7

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

125

2.09

3.08

2.0

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

5.01

3.05

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

496

1.52

3.04

1.2

1.1

13.5

9.9

u/ml

—

(3014271) Vancomycin [Susceptibility]

160

1.95

3.04

2.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.90

3.02

1.5

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

147

1.98

2.99

1.2

1.0

0.5

1.5

u/ml

0.83

(3039443) Prostate specific Ag panel - Serum or Plasma

409

0.46

2.99

1.3

1.7

—

(3022229) Phosphate [Moles/volume] in Urine

10.01

2.98

1.2

3.4

15.5

28.2

mmol/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

10.01

2.98

3.2

4.3

4.2

mmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2145

22329

0.88

2.98

4.2

1.4

1.3

mmol/l

7.66

1887

19856

(3013512) EKG study

897

8138

1.14

2.86

5.7

4.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

172

1.87

2.81

1.2

1.1

0.4

2.1

u/ml

0.87

(40768441) Liver Pathology biopsy report

152

1.92

2.75

1.6

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

364

1.58

2.73

1.4

9.4

9.8

u/l

0.12

291

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.01

2.72

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

388

1.56

2.72

4.5

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

118

2.04

2.71

1.1

0.7

3.2

u/ml

1.18

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.43

2.70

1.1

1536.4

1734.9

miu/ml

0.24

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.01

2.70

1.2

1.1

—

(3022145) Colonoscopy Study observation

319

2679

1.21

2.65

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.13

2.64

1.1

1.2

53.6

63.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

120

2.01

2.60

1.0

0.8

2.8

u/ml

1.10

(3018133) Calcium [Moles/volume] in Urine

3.61

2.57

2.2

2.1

1.6

3.2

mmol/l

—

(3020393) Adenovirus Ag [Presence] in Stool

4.01

2.56

1.4

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.36

2.55

1.3

1.1

—

(4198724)

3.04

2.52

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.38

2.47

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

414

1.51

2.46

1.9

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

131

1.92

2.40

1.3

1.1

nmol/l

0.51

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

335

0.47

2.39

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.35

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

2.01

2.30

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

520

1.43

2.30

1.2

1.3

896.4

545.8

mg/l

0.44

487

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

2.18

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.29

2.15

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

1.90

2.10

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.56

2.09

5.4

8.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.91

2.07

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.00

2.04

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

2.03

0.0

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

270

1.56

2.03

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

351

1.49

2.02

1.4

33.0

31.0

iu/l

0.14

297

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.64

2.01

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

443

1.43

1.99

1.2

1.5

111.8

816.2

e6/l

2.07

365

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.34

1.96

1.0

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.98

1.95

1.1

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.36

1.95

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.55

1.94

1.0

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

100

764

1.32

1.92

1.7

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.01

1.90

1.2

29.4

39.8

g/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1087

11581

0.91

1.90

4.6

5.6

5.0

4.6

ug/l

0.10

934

10294

(3005011) Chlamydia sp Ab [Titer] in Serum

3.19

1.88

1.3

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

1.86

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

107

1.87

1.86

1.1

1.0

0.4

0.3

u/ml

0.04

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

442

1.41

1.84

1.1

1.4

24.9

24.0

e6/l

0.02

344

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

285

1.52

1.84

1.7

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

253

1.55

1.84

1.8

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

198

0.45

1.83

2.8

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.17

1.82

4.0

7.2

—

(40768800) Prostate Pathology biopsy report

796

0.71

1.81

1.1

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2292

23541

0.90

1.80

5.2

5.1

6.1

mmol/l

0.12

2059

20924

(3016244) Insulin [Units/volume] in Serum or Plasma

2.06

1.80

2.9

2.8

11.9

20.7

mu/l

1.72

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

264

1.52

1.76

1.8

2.0

1.1

1.7

u/field

0.71

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

1.74

1.0

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.92

1.72

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2576

25216

1.12

1.69

22.8

10.4

24.3

25.4

u/l

2.40

2537

24036

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.39

1.67

1.1

—

(3000330) Specific gravity of Urine by Test strip

122

1513

0.80

1.67

5.6

3.5

—

(3003694) ABO and Rh group [Type] in Blood

659

6049

1.11

1.67

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

121

1501

0.80

1.66

1.1

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.80

1.65

1.0

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.07

1.59

1.1

1.2

26.4

22.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.11

1.55

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.89

1.54

1.0

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

214

1835

1.18

1.51

2.8

2.1

11.9

12.2

nmol/l

0.27

183

1576

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.86

1.50

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.07

1.49

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

210

1.53

1.48

1.3

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

1.75

1.46

1.1

—

(3048879) Bone marrow aspiration report

1.84

1.45

2.2

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

2.37

1.45

3.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

2.50

1.45

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

229

1.49

1.41

1.6

15.3

20.7

u/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

120

984

1.23

1.38

1.5

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

0.41

1.37

1.2

1.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.61

1.36

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.61

1.36

1.0

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

374

1.37

1.36

3.2

2.0

24.7

26.3

mg/l

0.07

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.94

1.36

1.0

2.8

—

(3044009) aPTT.lupus sensitive (LA screen)

2.94

1.36

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

1.83

1.35

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

112

1.70

1.35

2.3

1.7

—

(44813793)

115

1.66

1.24

1.0

—

(3019150) Specific gravity of Urine by Refractometry

579

5363

1.10

1.24

5.7

4.2

1.0

kg/l

0.52

103

832

(3032773) Endomysium IgG Ab [Titer] in Serum

164

1.53

1.20

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.88

1.18

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

123

1031

1.20

1.17

2.9

3.1

259.0

5033.8

u/ml

1.06

100

877

(4094501)

676

0.77

1.13

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

191

2180

0.87

1.12

1.4

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.38

1.09

1.2

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

338

1.34

1.08

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.76

1.06

1.8

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

613

0.76

1.06

3.6

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

121

1.57

1.05

1.0

1.8

5.4

15.0

umol/l

1.01

(3050129) First trimester maternal screen panel - Serum or Plasma

121

0.49

1.05

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

517

1.26

1.04

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

1.62

1.00

1.0

1.2

143.4

129.3

nmol/l

0.36

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

617

0.77

0.99

2.1

1.7

33.3

3.3

mg/l

4.29

452

(3000034) Microalbumin [Mass/volume] in Urine

240

1.38

0.98

1.8

3.2

28.2

22.7

mg/l

0.17

191

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.81

0.98

1.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.18

0.98

1.8

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

266

1.36

0.98

3.4

3.8

294.5

336.5

umol/l

0.93

226

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.67

0.97

3.4

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.67

0.97

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.82

0.92

1.9

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.14

0.91

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

0.87

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.82

0.85

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.94

0.84

1.8

2.4

0.5

0.4

u/field

—

(4027681)

1.57

0.84

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

153

1350

1.14

0.84

2.8

2.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

122

1.48

0.80

3.2

6.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

0.78

1.7

2.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.78

1.0

1.1

—

(3002256) Pathology report gross observation

361

3353

1.09

0.78

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.77

0.0

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.77

0.0

1.5

—

7.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

292

0.72

0.77

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

349

1.26

0.77

1.1

89.5

71.1

iu/ml

0.09

(40768793) Breast Pathology biopsy report

449

1.23

0.76

1.5

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

579

1.20

0.73

2.6

3.1

37.6

870.6

u/ml

1.18

532

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.80

0.72

3.3

1.9

—

(3044007) Cell count panel - Peritoneal fluid

1.62

0.71

2.1

1.9

—

(3025130) Human papilloma virus identified in Specimen

126

1.43

0.70

2.0

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.85

0.68

1.0

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.67

0.68

1.9

2.7

—

(4146454)

340

0.76

0.67

2.5

2.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.54

0.67

1.2

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

126

1121

1.13

0.65

1.1

1.2

105.1

131.5

iu/ml

0.31

403

(3023410) Appearance of Cerebral spinal fluid

189

1.33

0.64

1.3

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.73

0.64

2.8

2.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2271

22388

1.05

0.63

36.3

14.2

72.0

73.5

ml/min/173m2

2.25

2040

18492

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

105

0.57

0.61

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

105

0.57

0.61

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

105

0.57

0.61

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

105

0.57

0.61

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.0

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

713

1.15

0.60

2.4

2.2

127.1

81.7

ug/min

0.51

417

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.60

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.59

0.0

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.1

—

25.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

140

1.36

0.58

2.3

2.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

354

0.79

0.58

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.43

0.56

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.57

0.56

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.57

0.56

1.2

1.4

—

(3003338) MCHC [Mass/volume]

1925

18934

1.04

0.55

50.9

19.6

328.2

332.1

g/l

59.89

1906

18737

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.62

0.55

1.7

1.3

—

(1002224) Polysomnography panel

612

0.85

0.55

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

100

890

1.13

0.54

1.6

1.8

—

(4281824)

227

0.75

0.53

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.45

0.53

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

270

1.22

0.49

1.7

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

109

0.64

0.48

1.4

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

377

0.82

0.48

1.9

1.5

242.6

253.2

pmol/l

0.04

371

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

189

0.74

0.48

1.0

31.5

46.0

ng/l

—

120

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

188

0.74

0.46

1.0

281.2

328.2

ng/l

—

120

(3000285) Sodium [Moles/volume] in Blood

1.43

0.46

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.43

0.46

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

256

1.21

0.44

1.7

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.61

0.43

1.8

1.4

—

(3016879) Cocaine [Presence] in Urine

239

1.22

0.42

2.0

1.6

—

(40761535) Cells panel - Urine sediment

246

2319

1.07

0.42

5.1

3.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

122

1.31

0.42

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.56

0.42

2.0

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

472

1.15

0.41

1.5

1.8

4.8

4.2

iu/l

0.11

147

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.52

0.41

2.0

2.5

—

(3020650) Glucose [Presence] in Urine

1.36

0.41

1.8

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.0

—

(3028300) Cannabinoids [Presence] in Urine

259

1.20

0.40

1.9

1.6

—

(3027008) Opiates [Presence] in Urine

259

1.20

0.40

1.9

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

296

1.18

0.40

1.7

1.3

28.3

0.7

nmol/l

0.49

285

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

296

1.18

0.40

1.7

1.3

0.1

0.4

nmol/l

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2285

22622

1.04

0.40

6.9

6.5

42.1

40.6

mmol/mol

6.93

2112

20517

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.39

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

842

0.90

0.38

6.1

4.1

—

(3007461) Platelets [#/volume] in Blood

2616

25976

1.04

0.38

56.1

21.8

249.2

237.8

e9/l

12.33

2565

25148

(3024731) MCV [Entitic volume]

2616

25981

1.04

0.36

55.8

21.7

92.4

91.7

10.79

2581

25464

(3035941) MCH [Entitic mass]

2616

25981

1.04

0.36

55.7

21.7

30.3

30.5

3.00

2583

25466

(3026361) Erythrocytes [#/volume] in Blood

2616

25982

1.04

0.36

56.0

21.8

4.3

4.4

e12/l

44.04

2555

25060

(1001926) Buprenorphine [Presence] in Urine by Screen method

198

1.21

0.36

2.1

1.5

—

(3010813) Leukocytes [#/volume] in Blood

2616

25985

1.04

0.35

56.1

21.8

8.3

6.8

e9/l

70.17

2557

25056

(3011288) Drugs identified in Urine by Screen method

162

1.24

0.35

2.6

1.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

2616

25986

1.04

0.35

56.5

21.9

128.1

134.4

g/l

80.24

2583

25486

(3051593) INR in Capillary blood by Coagulation assay

173

1.22

0.32

7.4

16.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

445

0.87

0.32

1.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

258

1.16

0.31

2.0

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

258

1.16

0.31

1.7

1.3

—

nmol/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.71

0.30

1.0

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

250

0.84

0.30

1.2

7.5

7.7

mmol/l

0.08

176

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

155

1463

1.06

0.29

2.3

2.4

61.2

22.2

au/ml

—

(3022621) pH of Urine by Test strip

184

1748

1.06

0.28

4.9

3.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

138

1301

1.06

0.27

1.4

1.3

21.6

57.6

au/ml

—

(3011985) Renin [Units/volume] in Plasma

301

0.86

0.27

1.3

35.7

70.3

mu/l

1.26

261

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

118

0.76

0.27

1.2

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

119

0.76

0.27

1.4

1.3

6.3

6.2

mmol/l

—

112

(3033799) Differential panel - Peritoneal fluid

1.25

0.25

2.3

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.25

0.24

1.3

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

972

0.93

0.24

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.23

0.21

1.0

0.9

1.2

u/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.24

0.21

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

272

0.88

0.20

1.5

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

790

1.07

0.20

1.6

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

174

1.15

0.19

1.1

—

(3005570) Glucose [Moles/volume] in Urine

260

1.12

0.19

2.8

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.21

0.18

1.3

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

600

1.07

0.17

8.0

3.3

31.5

26.5

mg/l

0.59

378

(4024509)

273

1.10

0.16

1.5

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

638

6468

0.98

0.14

1.7

1.6

1.5

1.3

mmol/l

5.23

529

5367

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.19

0.14

1.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

474

1.06

0.11

2.6

1.4

1.0

0.8

nmol/l

1.18

391

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

280

0.93

0.10

1.3

214.6

279.9

pmol/l

0.76

212

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.14

0.10

1.4

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.15

0.09

2.2

2.1

163.4

769.8

e6/l

—

(3006270) Folate [Moles/volume] in Blood

248

0.93

0.09

1.1

1.2

287.6

331.7

nmol/l

0.49

190

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

174

1.09

0.09

3.4

5.1

137.8

38.0

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.11

0.09

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

1.07

0.07

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.11

0.06

1.7

1.1

—

(3045414) Leukocytes [Presence] in Urine

112

1143

0.98

0.06

2.6

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

228

2253

1.01

0.05

1.7

1.6

—

(3006462) Nitrate [Presence] in Urine

140

0.93

0.04

4.1

4.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

160

1.06

0.04

1.1

1.3

10.7

12.0

mmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

101

1.09

0.04

1.4

1.6

8.4

10.3

ug/l

0.28

(4034850)

812

0.98

0.02

14.6

10.9

—

(3008898) HLA-B27 [Presence]

496

0.99

0.00

1.0

1.1

—

(44806420)

105

0.95

0.00

1.8

2.6

—

(4211845)

155

0.97

0.00

3.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

156

1.03

0.00

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

1.02

0.00

1.0

1.1

—

(3019225) pH of Specimen

286

2856

1.00

0.00

6.1

4.1

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.97

0.00

2.2

1.5

8.6

3.6

ug/l

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.02

0.00

2.2

2.1

136.6

138.1

nmol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(4133840)

1.00

0.00

1.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

6.8

—

67.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1831.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.95

0.00

1.0

2.1

1.0

1.3

ug/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

211.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

385.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL_PNEUMONIA_SEPSIS – ILD, hospital admissions 3, with pneumonia sepsis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions 3, with pneumonia sepsis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints